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INTRODUCTION 
Coronary heart disease (CHD) is the leading cause of death in this 
country. It afflicts more than 29 million people and is responsible for 
about 1 million deaths per year. The incidence increases with age, from 
2-3% at 15-24 years of age, to 44% at 65 years or older [l]. The 
process and risk factors that produce the end result of CHD can be 
divided into three stages, are schematically represented in Figure 
1, by Connor and Connor [2]. Stage 1 in the development of CHD is the 
phase of relative hypercholesterolemia which occurs when a person is 
presented with a load of cholesterol in excess of its needs and its 
capacity to metabolize; and for most it occurs when the plasma cholesterol 
exceeds 180 mg/dl. The intensity of hypercholesterolemia is proportional 
to the degree that the plasma cholesterol exceeds this baseline value 
and the subsequent development of atherosclerosis is likewise related 
to the extent of hypercholesterolemia. Diet has a role in stage 1 in 
which it operates through its effect on plasma lipids. Although dietary 
factors are not crucial in the causation of hypercholesterolemia, for 
most Americans they are essential. After hypercholesterolemia has been 
present for a considerable time, stage 2 in CHD becomes manifest as 
atherosclerosis. The mature atherosclerotic lesion is characterized by 
accumulation of cholesterol esters (CE), triglycerides (TG) and phospho­
lipids (PL) and proliferation of fibrous, calcified tissue in the arterial 
intima. These lesions are followed by the actual occurrence of CHD in 
stage 3. Risk factors: age, hypertension, cigarette smoking, stress, 
physical inactivity are of secondary importance and they are chiefly 
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operative only when hypercholesterolemia is present. 
DIET 
Obesity 
HEREDITY 
HYPERCHOLESTEROLEMIA 
Hypertension 
ATHEROSCLEROSIS 
Physical Inactivity 
•Cigarette Smoking 
-Stress 
III CORONARY HEART DISEASE 
Figure 1. The stages and important factors in the development of 
coronary heart disease (Connor and Connor [2]) 
Nobody doubts that lipids are a major component of atherosclerotic 
lesions and the origin of these lipids may be twofold - local biosynthesis 
and derivation from blood. Even the lipoproteins (LP) to which the 
lipids are linked for transport have been blamed as having a role in CHD 
[3]. These complexes of protein with lipids are constructed with the 
polar molecules on the surface (protein and phospholipids and free 
cholesterol (FC)) and nonpolar molecules on the inside (triglycerides 
and cholesterol ester). The proteins on the surface of these LP carry 
the information that specifies the tissue to which different classes of 
lipid are to be delivered. There are four main types of LP, classified 
according to their size and density. These are the chylcxnicrons (CM), 
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which carry cholesterol from gut to the liver; very low density lipo­
proteins (VLDL) which carry cholesterol from liver to peripheral tissues; 
low density lipoproteins (LDL), which carry cholesterol whether obtained 
from diet or synthesized in the body to peripheral tissues and high 
density lipoproteins (HDL) which carry cholesterol not used by peripheral 
tissues back to liver where it may be excreted into intestine, or 
converted to bile acids or recycled back to peripheral tissues after 
incorporation into VLDL and LDL. 
The relationship of VLDL and its high TG content to CHD is not 
clear, since epidemiological studies do not present a clear picture. 
The Framingham study [3], Gothenburg study [4] and the Evans county 
prospective study [5] found that TG and VLD were not important risk factors 
for CHD; while in the Tromso heart study [6] and in the Stockholm prospec­
tive study [7], TG and VLDL were recognized as important risk factors. 
The causative role of increased plasma LDL in CHD has been well 
documented in almost all epidemiological studies. Attention has been 
focused on LDL as playing a key role in both the development of 
atherosclerotic lesions and in the regulation of cholesterol metabolism 
in cells other than liver cells. Brown and Goldstein [8] have developed 
extensive evidence that human cells have specific receptors for LDL 
binding. Following binding of LDL to receptors, the cell membrane 
invaginates to form vesicles to accommodate LDL inside the cell. These 
vesicles merge with lysosomes, whose enzymes digest the protein component 
of LDL and split off the CE with release of EC. The liberated EC has 
three important regulatory roles - it reduces cholesterol synthesis 
by suppressing the key regulatory enzymes, it activates another enzyme 
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which catalyzes the formation of new CE for storage, and it suppresses 
the synthesis of new LDL receptors, thus preventing accumulation of too 
much cholesterol by the cell. Lack of functional receptors could 
contribute to the increase in LDL concentration in two ways: peripheral 
cells would be unable to take up and metabolize LDL adequately. Also, 
the enzyme regulating cholesterol synthesis will not be suppressed and 
the cells would continue to produce the sterol in spite of high plasma 
cholesterol concentrations. 
Interest in HDL was stimulated largely by the finding that HDL is 
inversely related to CHD. Glomset [9] hypothesized that HDL transports 
cholesterol from the peripheral tissues to liver, thereby reducing the 
amount stored there and diminishing the likelihood of its ending up in 
atherosclerotic lesions. Although both iji vitro and ^  vivo evidence 
suggests the occurrence of such reversible cholesterol transport, it 
remains to be established that this mechamism diminishes atherogenesis. 
Connor [lO] summarized the relative pathogenicity of plasma lipids 
and LP for the development of atherosclerosis and this is shown in Table 1. 
Table 1. The pathogenicity of plasma lipids and lipoproteins for the 
development of atherosclerosis [10] 
Plasma Lipids and Lipoproteins Relative Pathogenicity* 
Cholesterol 4+ 
Triglyceride 1+ 
Chylomicrons 0 
VLDL 2+ 
IDL 4+ 
LDL^ 4+ 
HDL^ 0 
^Graded on a scale from 0 to 4+. 
^DL may be protective and in itself may tend to inhibit atherogenesis. 
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The concept of any disease arising from a single cause is obsolete 
and misleading. If one accepts the view that plasma cholesterol and 
lipoproteins constitute the etiologic agent in atherosclerosis, there 
still are constellations of interacting factors which may influence not 
only the concentration of serum lipoproteins, but also the susceptibility 
of arterial intima to lipid deposition. Any modification in the chemical 
composition of lipoproteins (FC:CE; CiPLj C:TG and others) can have a 
profound effect on exchangeability, accessibility and the chemical 
reactivity of lipid constituents and may lead to transfusion of lipo­
proteins with other molecules and membranes. 
The extent and severity of atherosclerosis are believed to be related 
to the factors including age, diet, blood cholesterol, high blood pressure, 
stress, physical inactivity. Therefore, this study was designed to 
analyze the effects of age and diet composition on cholesterol metabolism 
in leucocytes and plasma lipoproteins. This investigation will help under­
stand how cholesterol metabolism changes in peripheral tissues with age, 
and the role of diet composition. 
This dissertation consists of three papers. The first two papers 
deal with the development of methods and a model for studying cholesterol 
catabolism or bile acid synthesis in peripheral tissues. This includes 
the demonstration of cholesterol 7a~hydroxylase activity and presence of 
bile acids in human leucocytes and rat peripheral tissues. In the third 
paper, the leucocyte model developed in the first two papers is used for 
investigating the effect of age and diet composition on cholesterol 
metabolism in men. 
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REVIEW OF LITERATURE 
The focus of the following review of literature is on the use of 
the leucocyte as biopsy tissue for studying cholesterol and bile acid 
metabolism and the effects of age and diet composition on blood pressure 
and leucocytes and plasma lipoprotein lipids. Emphasis has been placed 
on research done with humans, and where applicable with experimental 
animals. In most instances, studies were limited to data on males. 
Leucocyte as Biopsy Tissue 
The accumulation of cholesterol esters in atherosclerotic lesions 
and their lethal complications stresses the importance of understanding 
the regulation of cholesterol metabolism in peripheral tissues ^  vivo. 
The present techniques used for studying in vivo regulaticm of cholesterol 
metabolism in humans include sterol balance, turnover measurements after 
injection of isotopically labeled cholesterol or its precursors and assay 
of biopsy tissues [2^]. These methods require steady state metabolic 
conditions and are time consuming and expensive or are potentially 
hazardous. These limitations also preclude sampling of large populations 
or repetitive sampling of individuals. Safe, quick and inexpensive 
techniques for studying the regulation of human cholesterol synthesis in 
vivo are needed. The use of leucocytes for studying cholesterol metabolism 
in peripheral tissue is under investigation. 
Peripheral blood leucocytes often mirror inborn errors of metabolism 
in that these cells may carry the enzymatic defect that underlies the 
disease. This characteristic has been dramatically demonstrated in the 
lipid storage diseases [l2] and in one form of hyperlipoproteinemia 
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[l3]. Hsia has reported that in more than 30 diseases, the leucocyte 
proved to be a useful indicator of an inborn error of metabolism. There is 
also strong evidence that in both lower animals and humans the tissue 
macrophages are derived from blood monocytes [l5,16,17]. Since the 
tissue macrophages participate in the formation of both tendcm xanthomas 
and the atherosclerotic reaction [l8], it seems reasonable to believe 
that the human leucocyte may serve as an excellent cell model in the 
study of atherosclerosis, Friedman et al. [l9] have reported the use of 
leucocyte count as a predictor of myocardial infarction and their data 
suggest that the predictive power of leucocyte count is similar to that 
of serum cholesterol or blood pressure. 
Ziats and Roberston [20] have also reported that blood monocytes 
may play a key role in arterial smooth muscle cell proliferation, a 
recognized event in the initial stages of atherosclerosis. All types of 
leucocytes contain the full range of lipid species encountered in most 
mammalian tissues. Lipids constitute about 5% of the wet weight of 
normal human leucocytes, and about one-third of the total lipid is 
neutral lipids, primarily free cholesterol and triglycerides. Gottfried 
[21] and Jaffe and Gottfried [22] have reported 5.33 |ig cholesterol per 10^ 
cells in granulocytes and 3.24 pig per 10^ cells in lymphocytes. They 
also observed very small amounts of cholesterol esters (CE) in human 
lymphocytes and granulocytes. Suzuki [23] also reported a predominance 
of free cholesterol (FC) in rabbit leucocytes (FCiCE=3jl) in contrast with 
predominance of cholesterol esters in plasma (FCjCE=lj2.5), Berghoff and 
Glatzel [24] suggested that leucocytes may have a role in the transport of 
absorbed fats \ihen they observed a 20% increase in lipid incorporation in 
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leucocytes after a high fat meal. 
Mixed human leucocytes [25] and isolated lymphocytes [26] can 
synthesize cholesterol from acetate. Fogelman et al. [27] have shown 
that the monocytes are five times more active than lymphocytes in choles­
terol synthesis from acetate or mevalonate; granulocytes, however can not 
synthesize cholesterol from either precursor. Higher activity in monocytes 
may be attributed to their larger cell size compared to granulocytes and 
lymphocytes. Fogelman also speculated that a relationship might exist 
between the short life span of granulocytes jji vivo (1-2 days) and the 
long life span of monocytes (3 months without division) and their respective 
abilities to synthesize sterols and hence replace cholesterol lost from 
their membrane. 
In a number of other ways also, leucocytes are an important species 
of cells for the study of cholesterol metabolism in peripheral tissues. 
Leucocytes behave as a nonendocrine, extrahepatic tissue and reflect LDL 
regulation of peripheral tissue cholesterol metabolism [28]. Their 
presence in the peripheral blood means that unlike other nonhepatic 
cells, such as fibroblasts, they are more easily available for repeated 
analysis; artifacts caused by passage of other nonhepatic cells through 
tissue culture are avoided; and activity of rate limiting enzymes in 
cholesterol metabolism can be determined in freshly isolated, unincubated 
uncultured leucocytes which have been in contact with endogenous lipo­
proteins, thus, reflecting the situation vivo. Thus leucocytes can 
help monitor the response of peripheral tissue to diet, drugs and surgical 
intervention. A person could serve as his/her own control for effects 
of various treatments. Lack of diurnal variation in leucocytes [29] 
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also facilitates experimentation since blood samples can be obtained at 
any convenient time of day. 
Effects of Age 
Leucocytes 
Helman and Rubenstein [30] studied the effect of age on total 
leucocyte count and observed that it does not change with age. Shapleigh 
et al. [31], Otani [32], and Zacharski et al, [33] also observed that 
total leucocyte and lymphocyte count remained constant from the 3rd to 
the 10th decade. 
Mackinney [34] analyzed blood counts of 184 inpatients and 884 
outpatients. They observed that the absolute lymphocyte count decreased 
from 2023 in people aged 20-29 years to 1872 in a 60-69 year age group. 
The lymphocyte count remained constant for ages 20-45 years then declined 
in subsequent years. This decrease may partially explain the decrease in 
cellular and humoral immunity observed in older people. They observed 
that granulocyte count does not show age dependent variations and remains 
constant throughout life. Reddy and Goh [35] also reported a decrease 
in lynç)hocyte count from 2548 in 20-40 year individuals to 2314 in 60-69 
year people. 
Letzky and Papisowa [36] studied the total lipid content of blood 
leucocytes in various age groups in men. They reported an increase 
in the lipid content of neutrophils and monocytes from birth to 35 years 
of age, after which it remained constant. 
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Blood pressure 
It is unanimously agreed at the present time that systolic and 
diastolic blood pressure are risk factors of CHD [37,38,39]. In the 
Evans county study [40], the CHD prevalence was 2.3 times higher in the 
subjects vAose blood pressure exceeded 160/90 mm Hg than in those with 
lower values. The western collaborative study [4l] showed the CHD 
incidence to be 3.6 times higher in the subjects with a diastolic blood 
pressure over 94 mm Hg than in those with a diastolic blood pressure below 
that value. A study based on the autopsy materials of the International 
Atherosclerosis Project [42] revealed a significant and positive correlation 
between hypertension and the severity of atherosclerosis. However, Chapman 
and Massey [43] noted no correlation between CHD and elevated blood 
pressure in their study of men aged below 60 years. 
Shaw et al. [44] reported that systolic blood pressure shows little 
change from 25 to 65 years of age, but after the age of 65, it increases 
markedly. Diastolic blood pressure significauitly increases from 25 to 
35 years of age with little further increase as aging progresses. Juustila 
[45] observed that in men systolic blood pressure increases steadily with 
age from 40 to 59 years, while diastolic pressure remains unchanged. 
The results of the first health and nutrition examination survey 
(HANES) in the U.S. [46] show that the mean systolic blood pressure in 
white men increased significantly and consistently with age from 119 ran Hg 
at age 18-24 years to 149 mm Hg at ages 65-74 years. The increment was 
lowest among young men 18-24 years (averaging 0.1 mm Hg per year); it then 
increased at a fairly steady rate from 35 years and older (an average 
of 0.8 mm Hg per year). The mean diastolic pressure in white 
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men also increased with age, reaching a maximum at ages 45-54 years, at 
a rate which declined from an average of 0.5 mm Hg per year in age 18-34 
years to 0,3 mm Hg per year at 35-54 years. The increase in diastolic 
pressure with age occurred at a slower rate and was less consistent than 
that of systolic pressure. The increase in mean diastolic pressure was 
from 73.8 mm Hg in age 18-24 years to 86.3 mm Hg in age 55-64 years. The 
proportion of individuals with both systolic and diastolic blood pressure 
substantially elevated (systolic pressure of at least 140 mm Hg and 
diastolic of at least 90 mm Hg) increased markedly with age from 4% in 
ages 18-24 years to 36% in ages 65-74 years. 
A positive association of serum cholesterol with blood pressure, 
though often suggested, has not been clearly demonstrated in man. It 
has, however, been shown by Deming et al. [47] that lowering blood pressure 
of hypertensives with a variety of agents does result in a fall in their 
serum cholesterol. Blood pressure does have some effects on cholesterol 
metabolism. Adel et al. [48] showed that vivo hypertensive rats 
synthesize cholesterol more rapidly than do normotensive rats. The 
changes ranged from 10 to 100 fold increase. They suggested that this 
effect on cholesterol metabolism is not a direct result of blood pressure, 
but reflects a change in tissue brought about by pressure. Juustila [45] 
observed that systolic hypertension was accompanied by high serum 
cholesterol. On the other hand, Olsson et al. [49] found that serum 
cholesterol had no correlation with either systolic or diastolic pressure. 
William et al. [50] did not observe any association between high density 
lipoprotein and blood pressure, but Hulleys and Ashman [5lJ observed that 
high HDL is associated with an increase in diastolic pressure. 
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Cholesterol levels in plasma and lipoproteins 
A rise in mean serum cholesterol with age has been reported in many 
studies. The mean serum cholesterol level in men tends to rise until a 
plateau is reached between the ages of 40-65 years, followed by a decline. 
Reported values at the time of peak vary from 230 to 245 mg/dl plasma 
[52,53,54] and in some instances higher levels have been noted [55,56]. 
Adlersberg et al. [57] observed that the increase in cholesterol with 
age occurs at the rate of 3.6 mg per dl of plasma per year. Boberg et 
al. [64] observed a slight continuous increase in plasma cholesterol from 
25 to 45 years of age, with little change from middle to old age in men. 
The HANES report [65] showed an increase in mean serum cholesterol with 
age from 189 mg/dl in 18 to 24 year old men to 251 mg/dl in 65 to 74 
year old men, which is an increase of 32%. The increase was steady from 
the 18-24 to 35-44 year age groups followed by smaller increments which 
reached a maximum at age 55 to 64 years and then slightly declined for 
the oldest age group studied (65-74 years). Serum cholesterol levels of 
men at ages 45-54 years showed a plateau following the early increase. 
The proportion of men with serum cholesterol exceeding concentrations 260 
mg/dl varied from a low of 4% in 18-24 year old men to 26% in 45-54 year 
olds. 
Lewis and coworkers [58] observed that LDL is more sensitive than 
serum cholesterol as a risk factor of CHD. They also reported that the 
highest LDL values are seen at ages 40-49 years. Goffman and Tandy [59] 
reported that LDL are strongly related to the risk of CHD only early in 
life (up through the 4th decade), with the predictive relationship 
weakening steeply in the next two decades; by 50-55 years of age there is 
little if any relationship of any serum lipid parameter with risk of 
future evolution of CHD. They also observed an increase in LDL with 
increase in chronological age in men during the 3rd and 4th decade, with 
peak LDL levels being reached at approximately 45 years of age, followed 
by a decline. The VLDL in men showed an upward trend during the 3rd 
decade, with an even steeper upward rise in the 4th decade, peak levels 
being reached during the 5th decade followed by declining levels as age 
increased. Low positive correlations in LDL and VLDL with increase in 
systolic pressure were also observed. 
Fredrickson et al. [60] have also observed an increase in plasma 
cholesterol, VLDL and LDL with age. They noted that the increase in LDL 
is slow but continuous through the 3rd decade, after which the rise takes 
place is at a more perceptible rate. They explained that this pattern 
could be attributed to cessation of growth and also to sendentary habits 
after age 30. Clark et al. [61] did a 12-year longitudinal study of serum 
lipids on the subjects from the U.S. Military Academy. They observed an 
increase in mean serum cholesterol from 183 to 237 mg/dl with increase 
in age from 19 to 31 years. An increase in LDL and downward trend of HDL 
were also noted. Results of Scott [62] and Allard and Goulet [63] also 
corroborate the age associated trends in LDL. 
Connor et al. [66] reported that in normal subjects the increase in 
plasma cholesterol is entirely in LDL, with insignificant increments in HDL 
and VLDL. Olsson and Carlson [67] also reported a significant positive 
correlation of serum cholesterol with VLDL (0.57) and LDL (0.81). 
Males show stable HDL concentrations during the first decade of life, 
lower values during puberty and adolescence, followed by stable values up 
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to 50-55 years, an increase around 60 years and a plateau thereafter [68]. 
Most population studies have reported no association between plasma and 
HDL cholesterol, while a weak positive association has been described by 
others [69], Examination of the relationship between HDL and LDL 
cholesterol had led to reports of either no significant correlation [70] 
or a negative correlation [7l]. 
The proportion of free to cholesterol esters (FCiCE) in the plasma 
is generally considered to be relatively constant. As early as 1936, 
Sperry [72] stated that the proportion of free to esterified cholesterol 
remains quite stable despite large differences in the total amount of 
cholesterol present. Similar observations have been made by Boyd [73] 
and Foldes and Murphy [74], However, Leonard et al. [75] reported that 
as the total amount of cholesterol in plasma increases, the increases 
in the free cholesterol fraction becomes proportionately greater than the 
increase in the esterified fraction, Lopez et al. [76] also observed that 
with advancing age there is a trend towards a proportional increase in 
the free cholesterol, but this was not statistically significant. 
No studies have been noted reporting the effects of age on the 
proportion of free and esterified cholesterol in lipoproteins. The 
results of Bragdœi et al. [77], Oncley et al. [78], Oncley [79] and Shen 
et al, [80] show the following FC to CE ratio in different lipoproteins. 
Lipoproteins FCiCE ratio (range) 
VLDL 1:1,2 to 1*1.6 
LDL 1:2.5 to 1:4,4 
HDL 1:1.6 to 1:5,0 
15 
Btle acid levels in plasma lipoproteins 
Uchida et al. [8l] and Dupont et al. [82] observed that the bile 
acid pool size of male rats does not change with aging, whereas Beher 
et al. [83] have reported a decrease in the bile acid pool size of male 
rats with increase in age. They observed that both cholic and cheno-
deoxycholic acid pool size decreased with aging. 
Bennion et al. [84 ] found no age effects on the bile acid pool size 
of normal men and women. 
No studies were noted reporting the presence of bile acids in lipo­
proteins other than HDL, According to Middlehoff et al. [85] the bile 
acid content of HDL in normal people is 8.5 nmol/ml plasma. 
Cholesterol and bile acid synthesis 
Most of the cells of the body have the capacity to synthesize 
cholesterol, but physiologically the liver and the intestine account 
for over 90% of the body's total synthesis. The synthetic pathway of 
cholesterol can be divided into four major steps. The first step is 
the production of 3-hydroxy-3-methylglutaryl CoA(HMGCoA) by condensation 
of three molecules of acetyl CoA by cystolic acetoacetyl CoA thiolase 
and HMGCoA synthase. The next step involves reduction of HMGCoA to 
mevalonic acid and is catalyzed by microsomal enzyme HMGCoA reductase 
and represents the overall rate limiting step of cholesterol synthesis[86]. 
Under physiological conditions, the HMGCoA reductase activity correlat«a 
with sterol production. Conversion of mevalonic acid to squalene with 
loss of one carbon at pyrophosphomevalonate decarboxylase comprises the 
third step. In the fourth step, cyclization of squalene with 
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the loss of 3 methyl groups yields cholesterol. Andersen and Oiatschy ^ 86] 
showed that serum lipoproteins exert 3 different types of effect in regula­
ting the Cholesterol synthesis in the body. These include regulation of 
chclesterogenesis in liver by CM remants, in extrahepatic, nonendocrine 
tissues by LDL, and in oidocrine tissues by HDL. 
Decrease in hepatic synthesis with aging has been reported by 
Bloch et al. [87], Srere et al. [ss]. Trout et al. [89], and Yanuunoto 
and Yamamura [90]. Kritchevsky et al. [9l] observed that the decrease 
in cholesterol synthesis with age occurs not only in liver, but also 
in extrahepatic tissues of the rat: spleen, kidney and colon. However, 
Story et al. [92], and Dupont et al. [82] did not observe any significant 
effect of age on cholesterol synthesis in rat liver. 
The ultimate degradation of cholesterol involves breakage of the 
ring structure, the capability of irtiich mammalian tissues do not possess. 
The transformation of cholesterol can only take place in those tissues 
which synthesize bile acids or steroid hormones. The first specific 
reaction in the biliary acid metabolic pathway is hydroxylation of 
cholesterol on the 7& position [92]. This reaction is catalyzed by 
microsomal enzyme cholesterol 7a hydroxylase and is the rate limiting step 
of the entire pathway [93]. Hruza and Wachtlova [94], Yamamoto and Yamamura 
[90], and Story and Kritchevsky [95] observed that bile acid synthesis 
in rat liver decreased with aging. Dupont et al. [96] also observed a 
decrease in rate of turnover of cholesterol to bile acids and proposed 
that decreased cholesterol catabolism can lead to an increase in serum 
cholesterol with aging. 
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Plasma and lipoprotein phospholipids 
A significant increase in plasma phospholipid (PL) concentration 
with age has been reported In many studies [97-101]. Boberg «t al. [64] 
observed that Increase in plasma PL Is slight but continuous from 25 to 
45 years and after middle age there Is very little change In PL levels. 
On the other hand, Clark et al. [ôl] and Berlin et al. [lOz] found that 
age had no effect on plasma PL levels, they remained more or less constant 
throughout life. 
Phospholipids are believed to be protective against a high cholesterol 
level, so that the cholesterol!phospholipid (CIPL) ratio has been 
advocated as an Index of atherogenesls. A high Incidence of athero­
sclerosis Is found In patients with nephrosis, hypothyroidism and essential 
xanthomatosis, where the plasma cholesterol exceeds that of phospholipids. 
Atherosclerosis Is not found In biliary obstruction or Von Clerk's 
disease where plasma phospholipids exceed cholesterol, even though the 
latter Is markedly above normal [l03]. In normal Individuals the ratio 
of C:PL tends to remain constant even though there are wide fluctuations 
In the normal level of cholesterol and phospholipid [l04]. Aldersberg 
et al. [57] reported that CIPL ratio Increases with age and for each 
1 mg/dl increase in plasma cholesterol, the Increase In phospholipid Is 
0.67 mg/dl. However, Clark et al. [61] found that CjPL ratio remained 
constant during their 12-year longitudinal study of serum lipids. 
Plasma and lipoprotein triglycerides 
Pelkonnen et al. [105] and Vik et al. [6] In the Tronso heart 
study and Carlson et ai. [7] in the Stockholm prospective study found 
18 
elevated plasma TG to be a significant risk factor for CHD, whereas in 
the Gothenburg study by Wilhelmsen [4] and the Evans country prospective 
study [5] TG were not a risk factor for men. 
Carlson [97] reported that serum triglycerides (TG) increased 
significantly with age in men from 0.85 mg/dl at age 26-30 years to 
115 mg/dl at age 40, and then remained constant to age 73 years. 
Fredrickson et al. [ôo] obsexrved an increase in plasma TG from 61 mg 
in 0-17 year old individuals to 104 mg/dl by 50-59 year old people. 
Carlson and Bottiger [l06j| in the same year reported an increase in 
plasma TG in men from 106 mg/dl in 20-24 age group to 151 mg/dl in 45-49 
age group and a decrease to 139 mg/dl in 60-64 year old men. Zweers et al. 
[107] also corroborated this age associated increase in plasma TG. 
Olsson and Carlson [67] studied serum lipoproteins of a random sample 
of 40-year-old men and reported significant positive correlations 
between serum TG and all lipoproteins TG, the strongest being with VLDL 
TG (0.95). They concluded that the increase in serum TG reflects mainly 
VLDL TG. Tobey et al. [1O8] reported that the age dependent increase 
in plasma TG is due to an increase in VLDL-TG secretion and a relative 
decline in efficiency of VLDL-TG removal from plasma. 
The use of cholesterol:triglyceride ratio to predict atherosclerosis 
has been proposed. An increase in CtTG ratio in VLDL may signify 
accumulation of atherogenic cholesterol-rich remnants of VLDL catabolism 
[109], An increase in LDL TG relative to C could reflect a more liquid 
crystalline, neutral lipid core [llO] which is in turn associated with 
decreased atherogenicity in the primate model [ill]. Knopp et al. [112^ 
examined a random sample of C?'<oasian men and women and observed no 
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significant effect of age on plasma lipoprotein CiTG ratio. The mean 
CiTG ratio for VLDL in men was 0.34, for LDL 7.84 and for HDL 4.50. They 
concluded that atherosclerosis of aging is not associated with a change 
in CtXG in lipoproteins. 
Food intake 
Munro [113] observed that the mean food energy calorie and protein 
intakes were decreased with increasing age, the decrease being from 3060 Kcal 
and 91 gm of protein in 22-year-old men to 2440 Kcal and 83 gm of protein 
in 60 year old men. The percentage of calories from protein increased 
from 11.9% in 22 year old men to 13.6% in 60 year old men. In the HAN ES 
report [ll4], the peak calorie and protein intakes in white males were in the 
18-19 year old group and thereafter they decreased, with the reduction 
being from 2973 Kcal and 114 gm protein in 20-24 year old men to 2112 Kcal 
and 74 gm protein in 55-64 year old men. In the survey the mean calorie 
intake of 45-74 year old men met, on an average, about 80% of the 
recommended allowance [lis]. 
McCandy et al. [lié] reported a significant age related decrease in 
total calorie intake in men; the annual average decrease was 12.4 Kcal/day. 
The percentage of calories derived from protein remained constant with 
increasing age, vrtiereas calories from fat dropped from 42% in the 45-54 
year old group to 36% in the 80 year old group* calories from carbohydrate 
increased. The daily intake of fat decreased with age from 123 gm in 
20-34 year old men to 99 gm in 65-74 year old group, and there was a 
concomitant decrease in cholesterol intake. Various reports have noted 
that the mean serum cholesterol intake decreases in the male population over 
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ages 50-60 years and this age associated decrease could be accounted for 
by a decreased fat intake. 
Effect of Diet Composition on Plasma Lipids 
No factor has been more highly correlated with serum cholesterol 
and lipoprotein levels than diet, whether by epidemiologic or metabolic 
studies. Delangen [ll7]. Snapper [lls]. Dock [ll9] and Keys [l20] were 
among those who called attention to the strong positive associations of 
dietary cholesterol, total dietary fat and animal foods to the occurrence 
of coronary heart disease (CHD). Product moment correlation coefficients 
computed between human CHD mortality rates and average daily intake of 
various nutrients for 30 countries are shown in Table 2, Dietary factors 
which correlate positively and significantly with the mortality rate 
from CHD include dietary cholesterol, animal protein, animal fat, total 
saturated fat, meats and eggs, as well as total calories and sugar. 
Carbohydrates 
High carbohydrate diets, at least on a short term basis, induce 
elevated levels of TG and VLDL and only a slight increase, if any, on 
plasma total cholesterol level [121, 122, 123]. Populations, however, 
consuming high carbohydrate diets habitually have a low incidence of 
atherosclerosis and do not have markedly elevated plasma TG |%24]. 
In the 1960s it was suggested by Yudkin and Roddy |l25] that the 
high sucrose consumption of the European American population might have 
an important role in the pathogenesis of CHD. Anderson et al. [126], 
Grande et al. [127] and Keys [128] have shown that in isocaloric feedings, 
carbohydrate derived from sucrose and lactose elevated, to some extent. 
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Table 2. Correlations between the mortality rates from coronary heart 
disease in m% aged 55-59 years and the intake of certain foods 
and nutrients (Delangen [117]; Connor and Connor [2]) 
Positive correlations (p < 0.05) 
Animal protein 0.782 
Cholesterol 0.762 
Meat 0,697 
Total fat^ 0.676 
Eggs 0.666 
Sugar 0.638 
Total calories 0.633 
Animal fat^ 0.632 
No correlations (p < 0.05) 
Plant sterols 0.144 
Fish 0.013 
Vegetable fat^ 0.011 
Vegetables 0.009 
Negative correlations (p < 0.05) 
Starch -0.464 
Vegetable protein -0.403 
^Data derived from the national statistics on food consumption and 
deaths from 30 different countries. 
^Data available from only 29 countries for these nutrients. 
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the serum cholesterol levels while those derived from cereals, grains, 
fruits and vegetables were without that effect. Little et al. [129] 
did not observe an increase in serum lipids by sucrose when compared to 
starch. Hyperlipidemic effects of dietary sucrose in humans were also 
not verified by other investigators [130,131]. 
Protein 
The possible effects of the dietary protein (both single protein 
sources and mixtures of several different proteins) on human plasma 
lipid levels has been extensively studied. Connor et al. [132] showed that 
the proteins consumed in mixed human diets have no significant effects 
upon plasma lipid levels. Anderson et al. [133] also did not observe 
any significant changes in plasma lipids with different quantities or 
sources of protein intake, so long as protein and amino acid requirements 
were met. Truswell [134] observed that in severe protein deficiency, 
plasma cholesterol in LDL and VLDL is lowered, but HDL is not affected. 
Cholesterol 
Reports on the effect of dietary cholesterol on plasma cholesterol 
have been very confusing. Keys et al. [135] and Ahrens et al. [136] 
reflected the prevalent opinion of the 1950s when they stated that the 
serum cholesterol levels are independent of dietary cholesterol. Wilson 
et al. [137], Grundy [136], and Mahley [139] also observed that the human 
response to dietary cholesterol is limited. They pointed out that most 
animal species are more sensitive to dietary cholesterol than is man and 
that humans have a remarkable ability to resist the absorption of dietary 
cholesterol and that hepatic cholesterol synthesis is suppressed in the 
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dietary cholesterol in amounts above 110 mg and up to 600 mg per day 
increased serum cholesterol concentrations. Beyond 300 mg/day, the rate 
of increase was small with increasing cholesterol intake, an observation 
suggesting a plateau effect. He also concluded that dietary cholesterol 
increased the body pool of cholesterol (both plasma and tissue) as well as 
the bile acid excretion, but did not suppress biosynthesis of cholesterol. 
The effect of dietary cholesterol on plasma cholesterol is probably 
not linear, and based on a review of experimental data in the literature. 
Keys et al. [l4l] estimated that one egg per day (250-325 mg cholesterol) 
added to the 600-700 mg of cholesterol consumed by the average American 
male would increase his dietary cholesterol by nearly 50% but his serum 
cholesterol concentration would increase by only 5 to 6 mg/dl. They 
did not estimate what effect a reduction in cholesterol intake by an amount 
similar to the addition of an egg would have. Previous reports of Keys 
et al. [l42] suggest that a dietary cholesterol reduction, would lower serum 
cholesterol by an amount greater than concentrations resulting from an 
addition of an egg. 
Fat 
The amount and kind of fat in the diet have a considerable effect 
upon the plasma lipid levels. A diet rich in polyunsaturated fats is 
generally associated with lower plasma lipid levels than one containing 
larger quantities of saturated fats [l43]. As early as 1952, Kinsell 
et al. [144] reported that animal fats raised plasma cholesterol, while 
vegetable fats lowered it. Ahrens et al. [136] have observed a positive 
correlation between the iodine value of dietary fats and their cholesterol 
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lowering properties. Keys et al, [l45] reported that saturated fatty 
acids with more than 12 but less than the 18 carbon atoms raised plasma 
cholesterol concentration, while polyunsaturated fatty acids had an 
opposite, but weaker effect than that of saturated fat. They observed 
that 2 gm of polyunsaturated fat were required to counteract the effect 
of 1 gm of saturated fat on serum cholesterol level. 
Jollife [l46] proposed that the effect of dietary fats on the 
serum cholesterol was a function of their ratio of polyunsaturated to 
saturated fatty acids (P/S), This concept that saturated fatty acids 
or dietary fats with low P/S are hypercholesterolemic is widely accepted. 
Ericcson et al. [l47] con^ared cholesterol-free formula diets of different 
P/S ratio of 0.1, 0.7, 1.5 and 1.6. They found that a high P/S ratio 1.6 or 
an extremely low ratio in the diet resulted in an identical plasma choies-
sterol levels and concluded that with a cholesterol free formula #iet the 
plasma cholesterol level is unaffected by the variation in the P/S ratio of 
diet. Shepherd et al. [148] studied the effects of diets rich and poor in 
polyunsaturated fats, with a P/S ratio of 0.25 and 4.0, and providing 
400 mg of cholesterol per day. They found that when compared to the 
diet with low P/S ratio, polyunsaturated fat diet decreased plasma total 
and LDL cholesterol and also HDL cholesterol by 33%, 
Populations having habitual diets rich in carbohydrate and low 
in fat (and usually low in cholesterol and saturated fats) have not only 
lower LDL cholesterol levels than westernized urbanized populations, 
but also lower HDL cholesterol levels [l49]. 
Considerable controversy still exists concerning the possible 
mechanisms by which dietary saturated and polyunsaturated fats influence 
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the plasma cholesterol levels. In normal humans, given polyunsaturated fat 
diets, an increase in the fecal output of bile acids and neutral sterols 
has been reported [l50]. Spritz et al. [l5l] and Kritchevsky et al. [l52], 
however, failed to observe increased bile acid excretion or synthesis with 
polyunsaturated fat diets. They suggested that redistribution of 
cholesterol body pools is responsible for the cholesterol lowering effect 
of polyunsaturated fats. Spritz and Mishkel [l53] have proposed that 
changes in lipoprotein structure by polyunsaturated fats cause cholesterol 
to leave plasma and enter tissues. The mechanism of action involved 
remains unsettled. 
Total calorie intake 
The excessive calories derived from any source whether fat, carbo­
hydrate, protein and/or alcohol, induce hypertriglyceridemia in some 
individuals by providing increased substrate for TG synthesis in the liver. 
This condition is usually associated with hypercholesterolemia tiiich is 
brought about partly by the concomitant increased intake of dietary 
cholesterol and fat and by the VLDL which transport both the increased TG 
content and cholesterol. According to Anderson and Keys [l54] who used 
diets with the traditional American (U.S.A.) fat distribution, eadi 1% 
rise in calorie Intake above the amount needed to maintain body weight 
will raise the serum cholesterol by about 2 mg/dl. But this 
increasing serum cholesterol reaches a plateau after approximately 10 
weeks, regardless of the positive caloric balance and weight gain 
that continue beyond 10 weeks. 
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ABSTRACT 
Evidence is presented for the identification of cholanoic acids 
and cholesterol Ta-hydroxylase activity in human leucocytes. Mono-
nucleated cells contained most of the detectable cholanoic acids. 
Cholesterol 7a-hydroxylase activity was present only in the mononuclear 
cells. These data suggest that cholanoic acids in leucocytes may have 
originated by local biosynthesis. Because of their lipid solubilizing 
properties, the cholanoic acids might have a function in the lAiagocytic 
activity of leucocytes. 
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INTRODUCTION 
The conversion of cholesterol into bile acids is catalyzed by 
microsomal enzymes and requires the transformation of cholesterol into 
7a-hydroxycholesterol. Cholesterol 7a-hydroxylase, the enzyme that 
mediates this transformation, controls the overall rate of bile acid 
synthesis [93]. Despite evidence that bile acids are present in tissues 
other than liver [155,156], it still is generally thought that this 
enzyme is localized only in liver microsomes [157,158]. Herein, we 
report both the presence of cholanoic acids and cholesterol 7a-
hydroxylase activity in human leucocytes and verification that 7a-
hydrocholesterol is the end product of the cholesterol 7a-hydroxylase 
assay. 
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MATERIALS AND METHODS 
Venous blood samples from normal healthy subjects were obtained 
by venipuncture in vacutainer tubes containing heparin. Mononuclear 
cells were isolated by layering over Ficoll-Paque (Pharmacia Fine 
Chemicals)[l59]. Monocytes were collected by adherence to culture flasks 
and nonadhering lymphocytes were eluted. Granulocytes were isolated from 
the lower Ficoll-Paque band. Leucocyte microsomes were prepared by 
following the method of Young and Rodwell [ZP]. Microsomal protein was 
determined by the Lowry procedure [160]. 
Cholanoic acids from lyophilized monocytes, lymphocytes, and 
granulocytes were extracted with chloroform*methanol (1:1). They 
were separated from other acidic lipids by thin-layer chromatography 
in a solvent system of toluene: ethanol:methanol:water:ammonium hydroxide 
(50*20*14:3:l)[16l]. Reverse phase high pressure liquid chromatography 
(HPLC), coupled with an ultraviolet detector set at 193 nm, was used 
for identification and quantitation of conjugated bile acids ^ 62]. 
Samples prepared in the elution solvent mixture (2 propanol: 8.8 nM 
potassium phosphate buffer, pH 2.5, 160*340), were analyzed on a 44 
mm x 30 cm |i Bondapak/C-18 column (Waters Associates) by eluting at 
1 ml/min. Quantitation was done by comparing the sample peak area with 
corresponding standards. 
Cholesterol 7a-hydroxylase assays were done by using the Carlson 
et al. method |163r| with the following modifications. A 0.3-ml sample 
of microsomal suspension in homogenizing buffer [29] was incubated at O^C 
for 10 minutes with 0.3 ml of potassium phosphate buffer (pH 7.4) 
containing 35 nM cysteamine, 0.15 ml of 4.5 nM MgClg, and 0.15 ml of 
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cholesterol suspension [0.1 ^ Ci of (4-^^C) cholesterol (54 ^ Ci/mmol) 
solubilized with the aid of 0.36 mg of Tween 80]. This allowed 
equilibration of exogenous and microsomal cholesterol. A substrate 
cofactor solution (0.15 ml) containing 0.75 mM NADP, 3 nM glucose 6 
phosphate, and 0.15 units of glucose 6 phosphate dehydrogenase was 
then added, and the mixture was incubated for 40 minutes, at 37^0 with 
shaking. Blanks containing boiled microsomes were run also. The 
reaction was stopped with 2 ml of ethanol. The assay conditions were 
such that, during incubation, 7a-hydroxycholesterol formed from 
cholesterol was not converted into intermediates further along the 
pathway or to secondary metabolites. 
Confirmation of 7a-hydroxycholesterol as the end product of this 
assay was accomplished by using electron-impact mass spectrometry. A 
Finnigan GC/MS/DS model 2709 was used to obtain the spectra by using 
the following conditions: 25 eV ionizing voltage, ion source temperature 
260°C, and 8.0 Kv acceleration voltage. Samples were introduced into 
the source chamber with a solid sampling probe. Commercially obtained 
7a-hydroxycholesterol (Steralcids, Inc.) was used as a reference 
standard. 
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RESULTS AND DISCUSSION 
The quantitation by HPLC of the cholanoic acids found is shown in 
Table 1. All cell types contained cholanoic acids. The granulocytes 
had very little as compared with concentrations in monocytes and 
lymphocytes (the mononuclear leucocytes). The cholesterol 7a-
hydroxylase activity in different leucocytes (Table 2) is expressed as 
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the percentage of C-cholesterol added to incubation medium that is 
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converted to C 7a-hydroxycholesterol, because the amount of endogenous 
cholesterol participating in the reaction was not determined. Most of 
the activity is in mononuclilear leucocytes, monocytes being 2.5 times 
as active as lym^Aocytes. This finding is consistent with the observation 
made by Fogelman et al. [27] that monocytes are 5 times more active than 
lymphocytes in cholesterol biosynthesis. We could not detect any 
activity in granulocytes, and this was not unexpected because inability 
of granulocytes to synthesize cholesterol has been demonstrated [164 ]. 
The mass spectrum (Figure 1) of 7a-hydroxycholesterol exhibited 
a molecular ion at m/e 402. The fragmentation observed had predominant 
M-18 (80%) and M-2x 18 (33%) peaks corresponding to the loss of water 
molecules. The peak at 253 suggested side-chain scission between C-17 
and C-20. The spectrum of the sample isolated from the leucocytes was 
virtually identical with that of a reference standard (Table 3). 
Cholanoic acid presence and synthesis in leucocytes has not been 
reported before. The probability of formation of the cholanoic acids 
in the mononuclear leucocytes by local biosynthesis is suggested by the 
presence of cholesterol 7a-hydroxylase, considered to be the rate-
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limiting enzyme in the biliary acid biosynthesis. Hydroxylated 
sterols do not accumulate in cells, so further reactions to form the 
bile acids identified are likely. The function and importance of these 
compounds in phagocytosis and immune responses will be an inqportant 
sequel to these findings. 
Table 1. Cholanolc acids in human leucocytes^ (range of 4 subjects) 
Leucocyte TC TCDC TDC GC GCDC GDC 
Monocytes 5.35 9.46 ND*^ 14.15 8.4 ND 
to to to to 
(tig per 10 cells) 5.65 13.5 20.29 13.83 
Lymphocytes 1.8 2.6 ND 4.15 3.04 0 
r to to to to to 
(jlg per 10 cells) 2.2 3.05 4.21 3.26 2.09 
Granulocytes 0.108 0.224 ND 0.219 0.314 ND 
to to to to g 
Oxg per 10 cells) 0.211 0.315 0.348 0.421 
^C = Taurodiolic; TCDC = Taurochenodeoxycholic; TDC = Taurodeoxycholic; GC = glycocholic; 
GCDC = Glyoochenodeoxycholicj GDC = glycodeoxycholic acids. 
^ot detectable. 
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Table 2. Cholesterol 7a-hydroxylase activity in human leucocytes (mean ± 
SD of 4 subjects). Percentage conversion of cholesterol to 
7a-hydroxycholesterol per 40 min per mg microsomal protein 
Leucocyte Activity 
Monocytes 0.760 * 0.252 
Lymphocytes 0.301 * 0.112 
Granulocytes Not Detectable 
MASS SPECTRUM OF 7 - HYDROXYCHOLESTEROL. 
100.0 57.1 •I.I 135.1 
SCO 
247.2 
3S4.2 
366.2 
100 150 
1 , 1 , I  
200 250 300 350 
402.0 
r-r-
400 450 
—r 
500 
MASS SPECTRUM OF 7 • HYDROXYCHOLESTEROL ISOLATED FROM HUMAN LEUCOCYTES 
100.0 135.1 
50.0-
M/E 
1191 143.1 
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150 
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199.1 2111 I 351.2 
.1. 1 , • •  A • 
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' h • 
400 
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Table 3. Fragment ions and relative intensities of 7a-hydroxyAolest erol 
isolated from human leucocytes vs. standard 
m/e Human leucocyte Standard 
402 2 1 
[M-n.l8]t 384 58 41 
[M-2«18]. 366 23 20 
[M-2.15+15]* 351 5 2 
313 0.5 0.5 
299 0.5 0.5 
271 3 3 
[M-149]* 253 12 10 
247 15 18 
229 4 5 
211 10 11 
199 7 8 
171 9 12 
158 35 45 
149 39 43 
143 39 61 
135 100 100 
119 47 66 
109 33 44 
95 46 78 
81 71 96 
69 37 70 
57 59 100 
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ABSTRACT 
The possibility of significant concentrations of bile acids 
in tissues other than liver and gut has been raised for a number of 
years. Problems of isolation and quantitation have hampered efforts 
to verify that possibility. Rat tissues and human leucocytes have been 
used in this study to show the identity, quantity and possible origin 
of cholanoic acids. Thin layer chromatography (TLC) and high performance 
liquid chromatography (HPLC) were used for isolation of cholanoic acids 
and the latter for quantitation. Quantitation also was done using a 
3a-hydroxysteroid dehydrogenase enzyme assay. Structures of glycocholic 
and glycochenodeoxycholic acids were confirmed by electron impact and 
chemical ionization mass spectrometry. The taurine conjugated acids 
isolated from tissues had spectra which matched authentic compounds. 
Rat kidney, heart, lung, adipose tissue, and human leucocytes 
were shown to contain these compounds. In addition, cholesterol 
7a-hydroxylase activity was found to be present in all the tissues 
examined. The unequivocal confirmation of cholanoic acids in nonhepatic 
tissues in significant amounts (7-20%) of hepatic concentration and 
the ability of tissues to synthesize hydroxylated sterols accentuate 
the importance of learning their functions in the tissues. 
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INTRODUCTION 
Unequivocal physical identification of individual nonhepatic bile 
acids is lacking, though there is evidence of the presence of cholanoic 
acids in brain [165] skeletal muscle, kidney, pancreas, and adipose 
tissue [155]. The presence of cholanoic acids in tissues raises the 
question of whether the compounds originated by local biosynthesis or 
by transfer from blood after synthesis in the liver. 
Bile acids generally occur in nature in free and conjugated forms 
and both are bound to proteins. Quantitative isolation of bile acids 
is difficult because of the physiochemical properties of bile acids 
and the presence of other compounds, particularly the acidic pigments 
and fatty acids. Numerous methods have been described for the isolation 
of bile acids from various sources [166-167]. Methods which utilize a 
vigorous hydrolysis step destroy the natural form of the bile acid and 
the separation of fatty acids from bile acids, particularly lithocholic 
and other less polar bile acids, poses a problem. Removal of fatty 
acids from samples is essential as they interfere with bile acid analysis 
by gas liquid chromatograi*iy (GLC). This is usually done by thin-layer 
chromatography (TLC) and different methods have been proposed for the 
separation of fatty acids from bile acids [168-170]. 
Evidence is presented herein for identification of individual 
conjugated bile acids, their quantitation by high performance liquid 
chromatography (HPLC) and 3a-hydroxysteroid dehydrogenase assay, and 
the possibility of their local synthesis. Improved methods of isolation 
are presented. 
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MATERIALS AND METHODS 
All chemicals used were of analytical grade. Free and conjugated 
bile acids were obtained from Supelco, Beliefonte, PA, and the sulfated 
bile acids were purchased from P-L Biochemicals, Inc., Milwaukee, HI. 
Precoated thin-layer silica gel G plates of 0.5 mm thickness and silica 
gel 60 plates of 0.25 mm thickness were obtained from VWR Scientific, 
San Francisco, CA. 
Rats were anesthetized with ether and the tissue sanqple e.g., heart, 
lung and kidney were excised and rinsed several times with physiological 
saline to remove traces of blood and then lyophilized. The equivalent 
of 2-4 gm of wet weight of tissue was used. The leucocytes were isolated 
from blood and the microsomes prepared by using the methods employed by 
Young and Rodwell [29]. 
Extraction Method I 
One gram of lyophilized tissue was saponified with 15 ml of N 
NaOH in 90% ethanol at 65°C for 1 hr with occasional mixing. The 
sample was cooled, 5 ml of water was added and the neutral steroids 
were extracted twice with 15 ml of petroleum ether. The petroleum 
ether extract was backwashed with 5 ml of N NaOH in 50% ethanol to 
remove traces of bile acids and mixed with the original extract. Ten 
ml of 50% ZnSO^'THgO were added to the petroleum ether extract and mixed 
thoroughly in a vortex mixer, then centrifuged for 10 min. at 3000 x g 
to remove most of the pigments. The supernate was decanted into a 500 
ml round bottom flask and the precipitate was suspended in 15 ml of 
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95% ethanol containing 0.1% ammonium hydroxide and heated at 65°C for 
30 min. The mixture was centrifuged again, the supemate decanted into 
the same round bottom flask and the precipitate was washed with 15 ml 
of 95% ethanol which also was added to the other washes. The pooled 
extract in the round bottom flask was evaporated to dryness in a rotary 
evaporator at 50-55^C under reduced pressure. The residue was then 
extracted with 20 ml of chloroform-methanol (1*1) which was evaporated 
almost to dryness under nitrogen in a water bath at 50-55°C. Any 
precipitate that came out was separated by centrifugetion. The liquid 
that remained was subjected to TLC for the separation of fatty acids 
from bile acids. 
Extraction Method II 
One gram of lyophilized tissue was homogenized with 25-30 ml of 
95% ethanol containing 0.5% HCl and incubated at 37°C for 1 hr [171]. 
The sample was centrifuged at 1000 x g for 10 minutes and the supernate 
was removed. Neutral steroids were extracted from the supemate with 
petroleum ether. The ethanolic residue was reduced in volume to 0.5 to 
1 ml by evaporation in a rotary evaporator at 50°C. 
Removal of Fatty Acids 
Frecoated silica gel G thin-layer chromatography (TLC) plates of 
0.5 mm thickness were used. The extract was spotted as streaks on 
the plates and a standard solution containing a mixture of glycocholic, 
lithocholic and oleic acids spotted at one corner of the plate. The 
plate was developed in a filter paper-lined chamber containing the 
solvent system toluene» ethanolimethanol:wa ten ammonium hydroxide 
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(50:20:14:3*1) for 1 hr at room temperature (27-28°C). The plate was 
air dried under the hood and redeveloped in the same solvent system 
for one hour and the plate was dried in the oven. The entire plate 
except the known bile acid standard channel was covered with aluminum 
foil and the exposed area sprayed with a manganous chloride spray 
reagent [172]. The plate was heated in the oven at 100°C for 10 min. 
and the area between glycocholic and lithocholic acid was marked. An 
alternative color reagent was 10% phosphomolybdic acid in ethanol, 
with the plate heated at 105°C for less than 2 min. The bile acid area 
was scraped off the plate and elated with chloroform-methanol (1:1). 
The extract was reduced to a volume of 0.5 ml under nitrogen at 50-55^C 
in a water bath. 
TLC Separation of Bile Acids into Groups 
Precoated plates of 0.25 ran thickness were used. The solvent 
system used was the same as reported earlier [l73]. in practice, a 
standard solution containing a mixture of glycocholic, glycolithocholic, 
taurocholic, taurolithocholic, cholic and lithocholic acids was spotted 
at one comer of the plate and the unknown bile acid solution was 
spotted as streaks. The plate was run in the solvent system ethanol: 
isooctane:isopropyl alcohol:ethyl acetate (25:10:10:10) for 2.5 hr and 
then dried and the standard bile acid channel was sprayed with a color 
reagent. The glycine conjugated bile acids lay between glycocholic 
and glycolithocholic, taurine conjugated bile acids between taurocholic 
and taurolithocholic and free bile acids between cholic and lithocholic 
acid. The zone corresponding to the different bile acid groups was 
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scraped off the plates and the bile acids eluted with chloroform methanol 
(1:1). The eluate was evaporated to a small volume for the identifica­
tion of individual bile acids. 
TLC Identification of Bile Acids 
The individual bile acids were separated on TLC by different 
solvent systems e.g., (i) isooctane:ethyl acetate:acetic acid (10:10*2) 
[174], and hexane:methyl ethyl ketone: acetic acid (63:40:6) [175] for 
free bile acids and (ii) isoamyl alcohol:acetone: acetic acid*water 
(63:26:6:5) [176] and isoamyl acetate:propionic acid*n-propanoltwater 
(4:3*2*1) [177] for glycine and taurine conjugated bile acids. The 
conjugated bile acids were hydrolyzed with 20% KOH in ethylene glycol 
and extracted through Amberlite XAD-2 column [178] and free bile acids 
were separated using TLC. The plate was sprayed with manganous chloride 
spray reagent and viewed under UV light and compared with authentic 
bile acids zrun on the same plate. With this reagent, less than a 
microgram of bile acids can be detected. 
High Pressure Liquid Chromatogra;*iy 
Reverse phase high pressure liquid chromatography (HPLC) coupled 
with an ultraviolet detector set at 193 nm was used for identification 
and quantitation of conjugated bile acids [l62]. Samples dissolved in 
the elution solvent mixture (2 propanol*8.8 nM potassium phosphate 
buffer pH 2.5, 160*340) were analyzed on a 4 ran x 30 cm (iBondapak/C 
18 column (Waters Associates) by eluting at 1 ml/min and 1 nQ. fractions 
were collected. Quantitation was done by comparing the sample paak 
area to corresponding standards. 
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Mass Spectrometry 
HPLC and TLC fractionated sample components were collected in glass 
screw cap vials and concentrated to dryness. Twenty (il of solvent was 
added to each vial to redissolve the sample residue and 5 |il of each 
transferred to quartz capillary sample cups for solid probe mass spectrom­
etry. The solvent was evaporated to dryness in the capillaries using 
a vacuum desiccator. Authentic compounds were used to obtain standard 
spectra. 
Chemical ionization (CI) mass spectra were run using a Finnigan 
4000 mass spectrometer and a Teknivent 29K interaction data system. 
Spectra were collected using the following conditions: 70 eV accelerating 
voltage, .025 torr source pressure CI methane, source temperature 260°C 
and manifold temperature 120°C. 
Cholesterol 7a-hydroxylase 
Leucocytes and rat tissues were analyzed for cholesterol 7a-
hydroxylase activity. The sample was homogenized and microsomal 
preparations were made from the homogenates [29]. The microsomal pellet 
was resuspended in 1 ml of homogenizing buffer. Microsomal protein 
was determined by the Lowry procedure [160] and free cholesterol by the 
method of Allain et al. [179]. Cholesterol 7a-hydroxylase activity was 
measured using the modified Carlson et al. method [163]. Conversion of 
cholesterol to 7-hydroxy cholesterol in this system has been verified 
[L80 ]. 
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Enzymatic Assay of Total Bile Acids 
Quantitation of bile acids in some samples was by a 3a-hydro-
xysteriod dehydrogenase (HSD) enzyme assay [181], The 3a-hydro-
xysteroid dehydrogenase obtained from Sigma Chemicals was prepared in 
0.01 M, pH 7.2 potassium phosphate buffer to give 3-4 units per ml. To 
0.1 ml of sample or standard, 0.15 ml of 0.005 M gNAD and 0.6 ml of 0.1 M 
sodium pyrophosphate were added and the mixture was allowed to equilibrate 
at 25^C for 15 min. Absorbance at 340 nm was recorded; then 0.1 ml of 
enzyme solution was added and the solution was allowed to equilibrate 
for 40 min. The change in absorbance was recorded at 340 nm. The 
concentration of unknown was determined from the standard curve. The 
correlation of this analysis with GLC analysis has been verified [182]. 
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RESULTS 
Extraction 
Method I was used for tissues subjected to TLC identification 
procedures. Method II was evaluated for quantitative recovery of 
added glycocholic acid (Table 1). From 88 to 93% of added radioactivity 
was recovered. The extraction method II [l7l] has been adopted as 
satisfactory for complete extraction. 
TLC Isolation of Bile Acids 
The TLC separation of bile acids from fatty acids is shown in 
Figure 1. It is evident from this figure that all the bile acids are 
clearly separated from fatty acids and cholesterol. Cholesterol moves 
far ahead of both bile acids and fatty acids. All bile acids, free or 
conjugated, lie between glycocholic and lithocholic acids except the 
sulfated bile acids. If sulfated bile acids are suspected to be in a 
biological specimen then glycolithocholic sulfate and lithocholic acid 
should be run as standards. All bile acids form a relatively narrow 
band which can be scraped from the plates after visualization with a 
color reagent. The solvent system should be freshly prepared and any 
remaining liquid should be drained from the chamber before fresh solvent 
is added. This solvent system is very useful to isolate the bile acids 
in their biological state without destroying the structure. The 
recovery of bile acids from the thin layer chromatogram by enzymatic 
assay was more than 90%. 
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Table 1. Recovery of added glycochollc acid by extraction method II 
added recovered 
cpm cpm % 
liver 13242 11918 90 
heart 11849 10901 92 
lung 11769 10945 93 
kidney 12879 11720 91 
adipose 13018 11456 88 
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Figure 1. Thin-layer chromatography on silica gel G of 0.5 nun thickness 
developed with toluene/ethanol/methanol/water/ammonium 
hydroxide (50:20:14;3jl,v/v/v/v/v) and visualized with 
manganous chloride spray reagent. 1 = glycocholic 
lithocholic and oleic acid (bottom to top); 2 = glycolithocholic 
sulfate; 3 = taurolithocholic acid; 4 = taurolithocholic 
sulfate; 5 = lithocholic sulfate; 6 = glycolithocholic acid; 
7 = glycochenodeoxycholic acid; 8 = taurocholic acid; 9 = 
taurochenodeoxycholic acid; 10 = cholic acid; 11 = hyocholic 
acid; 12 = hyodeoxycholic acid; 13 = chenodeoxycholic acid; 14 = 
cholesterol; 15 = glycocholic glycolithocholic, taurocholic, 
taurolithocholic, cholic, lithocholic and oleic acid. 
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TLC Identification of Bile Acids in Tissues 
The results of TLC identification of bile acids in heart, lung and 
kidney are illustrated by Figure 2. It appears that cholic acid is 
present in each tissue examined by TLC in the solvent system isooctanei 
ethyl acetatetacetic acid (10:10*2). It is apparent from Figure 2 that 
chenodeoxycholic acid is predominant in lung vdiile cholic acid is most 
abundant in heart and kidney. Traces of material were detected in 
bands corresponding to hyodeoxycholic and lithocholic acids. 
Physical Identification of Bile Acids 
The glycine conjugated bile acid spectra made using low ionizing 
voltages were quite similar to published spectra [183] (Table 2). The 
molecular ion and some other higher mass ions were not evident in the 
spectra. This was attributed to the small sample size and also possible 
interference from dissolved silica from the TLC plates. 
Attempts to improve the spectra by using chemical ionisation 
mass spectrometry were successful to a limited extent. The spectra 
generated did not resemble published EI spectra. Howevmr, the spectra 
of the reference standards and the isolated samples were virtually 
identical, thus, helping to establish the identity of the bile acids 
(Table 3). 
Neither the EI nor the CI spectra of the taurine conjugated bile 
acids closely matched the spectra published in the literature (Table 4). 
We thought that samples were thermally degraded in the sanqple probe. Spec­
tra of the commercial standards and the isolated samples were almost Iden­
tical to each other, however, and contribute to identifying the samples. 
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Figure 2. Thin-layer chromatography on silica gel 60 of 0.25-nm thick­
ness developed with isooctane/ethyl acetate/acetic acid (10* 
10:2,v/v/v) and visualized with manganous chloride ^ 
spray reagent and UV light. 1 - cholic, hyodeoxy 
cholic, chenodeoxycholic and lithocholic acid; 2 - heart) 
3 = same as 1; 4 = kidney; 5 = same as 1; 6 = lung; 7 = same as 
1. Top large bands in 2« 4 and 6 are pigment impurities. 
!  2.  
m/e 
465 
429 
414 
411 
396 
390 
372 
354 
336 
312 
299 
294 
281 
271 
253 
244 
226 
211 
199 
147 
145 
130 
117 
76 
30 
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Conparison of authentic glycine conjugated diolanoic acid electron 
inqpact spectra with published data and with a tissue compound 
isolated by TLC 
Glyoocholic Acid 
Reference 183 Standard Rat Kidney 
.4 
8.0 —— 
4.3 ——— —— 
8.8 ——— —— 
6.2 ——— 
2.3 
12.3 6.8 .8 
13.7 13.0 1.6 
2.9 —— ———— 
6.8 6.2 1.2 
5.0 ——— .5 
6.3 ——— 1.4 
7.5 —— 1.8 
90.6 73.8 71.6 
100.0 57.8 70.6 
8.8 1.6 4.9 
21.0 9.2 14.2 
15.5 4.0 10.4 
18.1 7.9 11.3 
23.6 5.0 17.4 
28.1 7.8 28.2 
15.2 38.2 26.9 
32.1 100.0 42.1 
17.5 13.9 7.6 
36.6 NA NA 
1.5 ———— ----
8.6 24.4 
6.5 " " " " — 
: 2. 
m/e 
413 
398 
374 
356 
338 
314 
401 
296 
283 
273 
255 
246 
228 
213 
201 
147 
145 
130 
117 
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(Coatinued) 
Glyoodiolic Acid 
Reference 183 Standard Rat Kiikiey 
30.9 42.8 —— 
45.2 75.8 
6.8 9.3 
7.9 64.3 
3.7 3.1 
15.1 52.1 —— 
2.5 3.1 ——— 
7.7 2.1 
3.8 .8 
18.6 7.7 
44.7 20.0 —— 
8.2 3.4 
14.2 6.7 ——— 
31.6 12.6 
18.1 7.6 
24.8 3.5 —— 
21.6 12.1 —— 
46.3 37.1 —— 
100.0 100.0 — 
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Table 3. Conparison of authentic glycine conjugated cholanoic acid chemical 
ionization spectra with tissue samples isolated by TLC 
Glycochenodeoxy dioli c 
Acid 
m/e Standard Adipose 
Tissue 
Glycodtolic 
Acid 
m/e Standard Adipose 
Tissue 
413 2.8 1.8 412 4.8 3.9 
398 0.7 - 411 8.9 -
373 6.3 3.8 
356 11.3 5.3 372 5.6 -
338 4.1 3.5 354 24.2 14.0 
353 26.4 -
296 0.8 0.8 337 45.3 30.2 
283 4.8 3.3 319 7.8 -
273 1.1 0.5 271 - 3.8 
255 45.4 52.9 253 13.2 14.0 
228 6.7 6.9 211 5.2 6.0 
213 13.5 13.5 199 4.6 5.0 
201 11.5 8.2 147 4.9 6.4 
147 17.2 15.1 145 5.4 7.8 
145 18.4 17.7 130 7.4 27,4 
130 5.6 6.1 117 29.8 36.4 
117 14.8 14.2 
lie 4 
m/e 
379 
353 
338 
337 
335 
320 
312 
299 
295 
294 
271 
253 
244 
243 
226 
211 
125 
Comparison of authentic taurine conjugated cholanoic acid chemical ionization 
spectra with tissue samples isolated by HPLC 
Taurocholic Acid Taurochenodeoxycfaolic Acid 
Reference Standard Human m/e Reference Standard Human 
183 Leucocyte 183 Leucocyte 
2.8 - - 385 - 4.6 -
16.7 13.1 4.6 381 2.5 - -
6.3 25.6 9.2 357 - 100.0 47.4 
- 100.0 29.6 355 100.0 25.6 13.8 
6.9 98.0 51.3 340 55.9 5.3 11.8 
4.9 30.9 3.9 339 - 21.7 53.2 
0.6 - - 337 14.9 - -
5.9 - - 322 10.0 - -
2.8 - - 314 2.7 - -
5.0 - - 301 42.0 50.0 -
0.9 - - 297 4.3 - -
100.0 12.5 9.9 296 5.1 - -
0.9 - - 283 12.4 - -
- 2.6 2.6 273 4.0 - -
6.1 2.6 4.6 257 - 9.9 19.7 
6.4 3.9 3.9 255 80.6 9.2 13.1 
- 61.8 63.1 246 3.5 - -
229 - 11.8 11.8 
228 11.5 - -
213 48.3 5.3 6.5 
127 - 71.0 75.7 
113 - 98.0 100.0 
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Quantitation of Bile Acids 
HPLC quantitation was compared to HSD assay. Results indicate 
similarity between HSD and HPLC quantitations (Table 5). Rat heart, 
lung, kidney and adipose tissue as well as liver contained cholanoic 
acids (table 6). They were predominantly taurine conjugated in the 
animals used (adult Sprague-Dawley male rats fed laboratory ration). 
Glycine conjugated compounds were present and could be concentrated 
by TLC as shown by the mass spectra data. Human leucocytes contained 
bile acids (Table 6). Glycine conjugated cholic acid (GC) was predominant, 
while for chenodeoxychollc acid, the taurine conjugated form was most 
abundant. 
Cholesterol 7a-hydraxylase Analyses 
The presence of cholesterol 7a-hydroxylase was demonstrated in 
non-hepatic rat tissue as shown in Table 7. Heart, lung and kidney 
tissues exhibited significant levels of activity; 23 to 32% of the level 
found in liver. Human mixed leucocytes had about 10% of the activity 
of rat liver per mg of microsomal protein. 
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Table 5. Correlation of HPLC and 3a-hydroxysteroid dehydrogenase (HSD) 
of cholanoic acids in rat tissues, r - 0.945 
HPLC HSD 
Tissue Total Cholanoic Acids 
per g tissue 
liver 165 153.4 
heart 13.9 10.8 
lung 11.8 10.9 
kidney 32.3 31.2 
adipose 5.2 4.4 
Table 6. HPLC quantitation of cholanolc acids in nonhepatic tissues 
Tissue Total TC® TCDC* TDC® GC® GCDC* GDC® 
Rat (|ig/g tissue) 
liver 165 115 49.5 ND^ ND ND ND 
heart 13.9 9.7 4.2 ND ND ND ND 
lung 11.8 4.4 7.4 ND ND ND ND 
kidney 32.3 15.4 11.3 3.4 2.2 ND ND 
adipose 8.2 2.4 3.4 2.4 ND ND ND 
Human ((Ig/nil blood) 
mixed leucocytes 1.5 0.49 0.13 ND 0.57 0.31 0.04 
*TC = Taurocholic) TCDC = Taurodienodeoxydwlic) TDC = Taurodeoxycholic) GC = Glycocholic; 
GCDC = Glyœchenodeoxycâiolic; GDC = Glycodeoxydiolic acids. 
^ot detectable. 
60 
Table 7, Cholesterol Ta-hydroxylase activity microsomes of selected 
tissues 
Tissue 
% Cholesterol 
converted to 
7a-hydroxycholes terol 
NMOLS of 7a-hydroixy-
cholesterol formed 
liver 
heart 
lung 
kidney 
per mg microsomal protein per 40 mn 
4.56 1.026 
1.45 0.203 
1.03 0.241 
1.34 0.378 
mixed leucocytes 0.247 0.113 
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DISCUSSION 
The identification of conjugated bile acids obtained by HPLC and 
TLC isolation from tissues validates the use of HPLC and other methods 
in which comparison to standards is used for identification of bile 
acids. The methods presented herein constitute relatively simple and 
effective procedures for isolation and quantitation of known bile acids 
from biological sources. For total bile acids, the HSD method is rapid 
and for individual bile acids HPLC allows identification and quantitation 
without the use of harsh deconjugation procedures. 
The presence of cholanoic acids in all tissues examined requires 
explanation. These compounds are toxic under some conditions [184] 
and are not likely to accumulate naturally without protective processes. 
Our data on the presence of cholesterol 7a-hydroxylase activity suggest 
that the compounds may originate in the tissue analyzed and not from 
blood circulation. Further verification of this with identification 
of intermediates is required. 
Bile acids have been known to be required for pancreatic cholesterol 
esterase activity for many years [185]. A recent publication [186] 
describes a requirement for bile salts for human carboxyl ester 
hydrolase from pancreatic juice to hydrolyze esters of cholesterol and 
vitamins A, D-3, and E. 
In a review of cholesterol efflux from cells, Phillips et al. [187] 
concluded that a large unstirred water layer affects the transfer of 
cholesterol between cells and acceptors in a medium. Bile acids are 
obviously suitable mediators of lipid transport across unstirred water 
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layers [188]. 
In addition to possible functions of cholanoic acids as mediators 
of sterol efflux from cells through the unstirred water layer, cholesterol 
efflux requires that the cholesterol be in the free form [189]. Any 
stored cholesterol ester must first be hydrolyzed to cross the membrane. 
Regulation of hydrolysis and esterification could be mediated by 
cholanoic acids. Hydroxylated sterols are known to be potent activators 
of cholesterol esterase [190]. Cholesterol synthesis has been shown 
to be required for leucocyte chemotaxis [I9l]. Further investigation of 
the possible functions of cholanoic acids in non-hepatic tissues is 
warranted. 
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PAPER III. EFFECT OF AGE AND DIET COMPOSITION ON BLOOD PRESSURE 
AND CHOLESTEROL METABOLISM IN PLASMA LEUCOCYTES AND LIPOPROTEINS 
IN MEN 
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ABSTRACT 
The effects of age and diet composition on the cholesterol metabolism 
in plasma leucocytes and lipoproteins of healthy men of three different 
age groups (19-25, 40-50 and 60-70 yrs) were studied. The cholesterol 
levels in the leucocytes, plasma, VLDL and LDL of the 60-70 year old men 
were significantly higher than those of the two younger groups, vrtiereas 
HDL levels were very similar in all the three age groups. The mean HMGR 
and COH activity in the two older groups was significantly higher than 
in that of 19-25 year old men. With increase in age, plasma and VLDL 
triglycerides increased significantly, whereas no significant changes 
in phospholipid and bile acid levels in plasma or lipoproteins were 
observed. The dietary intake of calories, carbohydrates and fat in 19-25 
year old men differed significantly from 40-50 year old men, but not 
from the 60-70 year old men. Most of the dietary variables examined had 
no significant effect on plasma lipids. The results suggest that diet 
is not responsible for the age related increase in plasma leucocyte and 
lipoprotein lipids. The increase in plasma cholesterol in the oldest 
age group may reflect a decrease in number or function of the peripheral 
cell receptors. 
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INTRODUCTION 
The dominant role that coronary heart disease (CHD) plays in the 
cause of death in this country underscores the inqwrtance of athero­
sclerosis as a population health problem. The incidence increases with 
age, from 2.3% at 15-24 years of age to 44.0% at 65 years of older [l]. 
That high serum cholesterol levels are iiiq;>licated in atherosclerotic 
progression is indisputable. The lipoproteins which transport cholesterol 
have also been indicted in the development of atherosclerosis. The low 
density lipoproteins (LDL) carry cholesterol to the peripheral tissues 
where it is used and the high density lipoproteins (HDL) may return 
cholesterol from peripheral tissues back to the liver. Epidemiological 
evidence suggests that high concentrations of LDL increase the risk of 
CHD, whereas high concentrations of HDL decrease that risk [192]. Many 
studies have reported a rise in serum and LDL cholesterol and a decrease 
in HDL cholesterol as age increases [58,6l,65J. Juustila [45j observed 
that systolic hypertension was accompanied by high serum cholesterol 
concentrations. Six decades of evidence have provided a considerable 
degree of certainty that the level of plasma and lipoprotein cholesterol 
is determined partially by the intake of calories, fat and cholesterol 
[193]. However, it is still not known to what extent diet is responsible 
for the age-related changes in plasma and lipoprotein choiestrol. 
The atherosclerotic plaques are characterized by the accumulation of 
cholesterol and its esters in the peripheral tissues. These deposits 
could come from three sources namely, increased influx from blood 
mediated by an increase in LDL} excess cholesterol synthesis in peripheral 
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tissues! and decreased efflux from peripheral cells mediated by HDL. 
This stresses the importance of understanding the regulation of cholesterol 
synthesis and utilization by peripheral tissues ^  vivo. The uttfulness 
of leucocyte for studying cholesterol biosynthesis in peripheral tissues 
has been reported by Fredrickson and Sloan [12], Hsia [14] and Fogelman 
et al. [13]. We have evidence that the leucocytes can also 
synthesize bile acids, the end product of cholesterol catabolism [180]. 
An indicator of cholesterol metabolism in peripheral tissues is therefore 
envisioned in the leucocyte. It is believed that the leucocyte will 
reflect ^  vivo responses of peripheral tissue to factors affecting 
cholesterol metabolism. Therefore, the present study was designed to 
use leucocytes for investigating the effects of age and diet composition 
on cholesterol metabolism in peripheral tissues of adult men. 
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MATERIALS AND METHODS 
Selection and Description of Subjects 
The subjects for this study were 29 men from three different age 
groups (19-25, 40-50, and 60-70 years) who were students, and current and 
former employees at Iowa State University. All were lAite (Caucasian 
background) and in apparent good health. None of the subjects were 
engaged in regular jogging, swimning or other training exercises. Infor­
mation describing these men is given in Table 1. 
Dietary Data, Blood Pressure and Blood Saaqple Collection 
The subjects were instructed how to record their food intake in 
household measures for three consecutive days which consisted of two 
weekdays and one day of the weekend. The diet records were analyzed for 
their energy and nutrient content by using a coiq>uter program based on 
food values in the Agriculture Handbook, 456 [194]. Within the same 
week diet records were kept, a 100 ml sample of fasting blood was drawn 
once by venipuncture in EDTA vacutainer tubes. Blood pressure was 
recorded before drawing blood by using sphygnomanometer. 
Laboratory and Data Analyses 
A 30 ml blood saiq>le was used for the separation of mixed leucocytes 
[29], 30 ml for separation of mononuclear leucocytes [159], and the rest 
of the sample for plasma and lipoprotein separations [195]. The number of 
cells was determined by coulter counter and differential count with Wright 
stain [196]. Mixed leucocytes were lyophilized and extracted with 
chloroforms methanol (1:1 v/v). The biochemical tests performed on plasma, 
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lipoproteins and mixed leucocytes included determination of cholesterol 
(free and ester), total bile acids, phospholipids and triglycerides. 
Total and free cholesterol concentrations were determined by the method 
of Allain et al. [179] and cholesterol ester represented the difference 
between total and free cholesterol. Total bile acids were analyzed by 
the method of Turnberg and Anthony-Mote [l8l]; phospholipids by using 
the method of Sandhu [197], and triglycerides by the method of Fletcher 
[198]. Microsomes from mononuclear cells were prepared by the method of 
Young and Rodwell [29] and HMGCoA reductase activity was measured in 
microsomes also using Young and Rodwell's procedures. Cholesterol 
7a-hydroxylase activity was measured in mononuclear microsomes using the 
modified Carlson et al. method (163). The methods used are included in 
Appendix B. 
Paired Student t-tests were performed on the dietary, clinical and 
biochemical data to examine effects of age. Correlation coefficients 
between selected variables were also calculated. 
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RESULTS 
General Characteristics 
Table 1 shows the characteristics of the subjects studied. They 
ranged from 19-68 years of age and were divided into three age groups* 
19-25 years, 40-50 years, 60-70 years. The mean weights and relative 
weights of the subjects in the three age groups did not differ signifi­
cantly. The mean systolic pressure of 60-70 year old men was signifi­
cantly greater than those for the 19-25 and 40-50 year old men, but the 
diastolic pressure of men in the three age groups did not differ signifi­
cantly. 
Dietary Composition 
Diet composition data (Table 2) show that the total calories, fat, 
protein, and carbohydrate intakes of 19-25 year old men differed 
significantly from the 40-50 year old men, but not from the 60-70 
year old men. The mean saturated and the polyunsaturated fatty acid 
intakes of the two older groups studied were significantly lower than that 
of the 19-25 year old group of men, trtiile the polyunsaturated to saturated 
ratios of the diets were similar among the three groups. The percentages 
of calories derived from fat, protein and carbohydrate were not 
significantly different among the three age grovq)s. 
Leucocytes 
There was no significant difference in the number or proportion of 
leucocytes as age increased (Table 3). However, the cholesterol content 
of leucocytes of the oldest age group studied was significantly higher 
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than the mean values for the two younger groups. The mean total bile acid 
levels were similar in all three age groups. 
Our previous work [180] has shown that the mononuclear leucocytes 
possess hydroxymethylglutaryl coenzyme A reductase (HMGR) and cholesterol 
7a-hydroxylase activity (COH). Hydroxymethylglutaryl coenzyme a reductase 
is the rate-limiting step in the synthesis of cholesterol [199]. The mean 
HMGR activity for the 40-50 and 60-70 year old men was significantly 
higher than that for the youngest age group when activity was expressed as 
per mg microsomal protein or per 10^ mononuclear cells or per ml blood 
(Table 4). Cholesterol 7a-hydroxylase is the rate limiting step of 
bile acid synthesis [93]. When expressed as per mg microsomal protein 
or per ml blood, its activity was similar for the three age gropps. But 
when values were expressed as per 10^ mononuclear cells, the COH activity 
for the 40-50 and 60-70 year old men was significantly higher than 
that observed in the 19-25 year old men. This particular trend reflects 
the decrease in the proportion of mononuclear cells with increase in 
age. 
Plasma 
Table 5 shows the concentration of various lipids in plasma. The 
mean plasma cholesterol values increased significantly with increases 
in age from 19 to 70 years and the mean annual change was 1.57 mg 
cholesterol per dl plasma. The magnitude of increase in plasma free 
cholesterol and cholesterol ester with age was similar, consequently free 
to ester ratio did not change with increased age. For the plana lAos-
pholipid, mean values were similar in all three age groups, although a 
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significant increase in cholesterol to phospholipid ratio with increase 
in age was observed. Plasma triglycerides increased significantly for 
the successive age groups with 93 mg/dl in the 19-25 group, 107 mg/dl 
in the 40-50 group and 122 mg/dl in the 60-70 group. The mean values 
for plasma bile acids did not differ significantly among the three age 
groups. 
Lipoproteins 
The levels of various lipids in the different lipoproteins are 
shown in Table 6. The change in VLDL total cholesterol with advancing 
age was not significant, while its free cholesterol was significantly 
higher in the 60-70 age group than in the 19-25 age group. The LDL 
cholesterol increased significantly with increase in age at a mean rate of 
1.29 mg per dl plasma per year. The degree of rise in LDL cholesterol 
ester was proportionately greater than the increments in its free choies*^ 
terol from 19-25 to 40-50 years, but the increase in both free and ester 
was significant from 40-50 to 60-70 years. There were no significant 
changes in HDL cholesterol and in the free to ester ratio. 
All three age groups showed similar mean phospholipid concentrât 
tiens in all the lipoprotein fractions analyzed. VLDL triglycerides 
increased significantly with advancing age, while LDL and HDL trigly­
cerides remained unchanged. Bile acids were found to be present in all 
the three lipoprotein fractions, U)L, VLDL and HDL, and these amounts 
accounted for almost all the plasma bile acids. The lipoprotein bile 
acids tended to decrease with increase in age, but this trend was not 
significant. 
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Correlation coefficients between selected variables are shown 
in Tables 7 and 8. These are discussed later in the paper. 
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Table 1. Characteristics of men of 3 age groups (mean and range) 
Variable 19-25 
n*lO 
Age Groups, yr 
40-50 
n=9 II 
Age Cyrs) 22.4 (19-25) 43.8 (40-50) 64.0 (61-68) 
Weight (lbs) 
.1 
175.8* (143-199) 173.8^(136-208) 172.6*(127-195) 
Relative weight^ 99.5*(83-109) 98.3*(83-108) 102.3*(78-120) 
Blood Pressure (mm Hg) 
Systolic 118.4^(94-152) 115.5*(88-140) 136.6^(120-156) 
Diastolic 70.2*(56-84) 76.7*(62-98) 78.8*(58-96) 
«eans with different letter superscripts within the same row are 
significantly different (p < 0.05 or p < 0.01). 
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Table 2. Diet composition of healthy men In 3 different age groups (Mean 
of 3 days ± Standard error of mean) 
Age Groups, yr 
Variable 19-25 40-50 60-70 
n=10 n=9 n=10 
1) Protein(e) 102^ + 9 77^ ± 10 106* ± 17 
2) Carbohydrate (g) 310* ± 27 208^ ± 24 258*^+ 21 
3) Fat(g) 
Total 120* ±9 83^ ± 10 94*^± 13 
Saturated 49^ 30^ 34 
Oleic 45* 30^ 34*^ 
Linoleic 21* 13^ 14^ 
p/gZ 0.402* 0.451* 0.443* 
4) Cholesterol (mg) 456* ± 68 335 ^  ± 61 415^ ± 68 
5) Calories 
Total 2763* ± 179 1927^ ± 223 2322*^± 197 
Protein (%) 15^ 16^ 18* 
Carbohydrate (%) 46* 45* 46* 
Fat (%) 39* 39* 36» 
^Means with different letter superscripts within the same row are 
significantly different (p < 0.05 or p < 0.01). 
2 Polyunsaturated ; saturated fatty acid ratio. 
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Tablo 3, Total and differential leucocyte count, and cholesterol and 
bile acid concentrations in leucocytes of healthy men in 3 
different age groups (Mean ± Standard error of mean) 
Variable 19-25 
n=10 
Age Groups» yr 
40-50 60-70 
n=9 n=10 
Leucocytes 
Total number of 
leucocytes 
Mononuclear 
leucocytes (%) 
Granulocytes (%) 
Cholesterol (|ig per 
108 cells) 
7194 ±4 74 
44 ± 2.7 
56*± 2.7 
6494* ± 417 
40*+ 3.4 
60*± 3.4 
7816® ± 694 
38*± 2.9 
62*t 2.9 
Total 
Free cholesterol 
Cholesterol ester 
Bile acids (nMoles 
per 10 cells) 
101 ±11.9 
78*± 10.3 
23*± 3.1 
2.11 ± 0.164 
106 ± 14.3 
79*+ 10.8 
27*± 3.8 
2.16 ± 0.252 
133 ± 28.1 
100^+ 18.9 
35*± 9.4 
2.11 + 0.178 
Means with different letter superscripts within the same row are 
significantly different (p < 0,05 or p < 0.01). 
Table 4. Hydroxymethylglutaryl coaizyme A reductase (HMOt) and cholesterol Toc-hydroxylase 
(COH)^ activity in mononuclear leucocyte microsomes of healthy men in 3 different 
age groups (Mean + Standard error of mean) 
Age Groups, yr 
19-25 40-50 60-70 
n=10 n=9 n=10 
HMOl COH HMGR COH HMGR COH 
Per mg microsomal 10.^ 0.10^ 13.1 0.107® 14.4b 0,128® 
protein * t ± ± • ± ± 
0,54 0,0059 0.81 0.0051 1.22 0,0113 
Per 10^ mononuclear 30,4* 0,303® 51.4^ 
ab 
0.419 45.2^ 
b 
0,401 
cells ± ± + + + ± 
3.24 0,0300 6.52 0.Ô549 4.10 0,0386 
Per ml blood 9.f 0,091* 12.2^ 0.099® 
b 
12,5 0,110® 
± ± 
+ + + + 
0.49 0,0054 Ô.75 0.0079 0,77 0,0069 
^Enzyme activity was expressed as p mois of mevalonate formed per hour. 
^Enzyme activity was expressed as % of ^^C-cholesterol converted to ^^C-7a-
hydroxycholesterol per 40 minutes. 
^Means with different letter superscripts within the same row are significantly 
different (p < 0,05 or p < 0.01). 
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Table 5. Cholesterol, phospholipid, triglyceride and bile acid levels 
in plasma of healthy men in 3 different age groups (Mean ± 
Standard error of mean) 
Variable^ 
(per dl plasma) 19-25 
n=10 
^e Groups, yr 
40-50 
n=9 II 
TC (mg) 
2 
204» ± 5.4 232^ ± 11.1 283® ± 8.3 
FC (mg) 53® ± 1.8 62^ ± 4.2 74® + 2.1 
CE^(mg) 150» + 3.9 170^ ± 7.2 209° ± 7.1 
PL (mg) 210® +20.5 208® + 10.7 215® +21.7 
TG (mg) 93® + 3.5 107^ + 7.2 122° + 5.5 
BA (nM) 0.749® + 0.077 0.767® + 0.094 0.609®+ 0.056 
FC/CE 0.35® 0.36® 0.35® 
TC/PL 0.97® 1.11^ 1.32° 
^TC = Total cholesterol, CE = Cholesterol ester, FC - Free cholesterol 
PL = Phospholipids, TG = Triglycerides, and BA = Bile acids. 
^eans with different letter superscripts within the same row are 
significantly different (p < 0.05 or p < 0.01). 
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Calculated CE = Total cholesterol minus free cholesterol. 
Table 6. Cholesterol, phospholipid, triglyceride and bile acid levels in lipoproteins 
of healthy men in 3 different age groups^ (Mean ± Standard error of mean) 
Age 
groups 
(yr) 
TC 
(mg) 
FC 
(mg) 
CE^ 
(mg) 
PL 
(mg) 
TG 
(mg) 
BA 
(VlM) 
FC 
CE 
TC 
PL 
per dl plasma 
Very low 19-25 
3 
20.4* 4.7* 15.7* 33.2* 54.5* 0.105* 0.30* 0.61* 
density ± + + ± + + 
lipoprotein 0.97 0T24 O789 2.20 2723 0.007 
40-50 21.3* 5.3*b 17.0* 29.8* 64.4b 0.104* 0.31* 0.7l*b 
± ± ± é + + 
2.35 0.67 1.46 1.47 3,08 0.006 
60-70 24.9* 6.5b 18.4* 30.3* 83.7C 0.097* 0.35* 0.82*^ 
± + + * + + 
2.09 0.57 1T53 2.36 4.18 0.055 
^TC = Total cholesterol, CE = Cholesterol ester, FC = Free cholesterol, PL - Phospholipids, 
TG = Triglyceride, BA = Bile acids. 
2 Calculated CE = Total cholesterol minus free cholesterol. 
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Mean values not sharing a common letter superscript are significantly different (p < .05 
or p < .01), 
Table 6. (Continued) 
lipoprotein 
Age TC FC CE^ PL TG BA FÇ TC 
groups (mg) (mg) (mg) (mg) (mg) (pM) CE PL 
per dl plasma 
0.31® 1.04* 
0.27® 1.38® 
lipoprotein 
19-25 127.1* 30.4* 96.7 121.9* 24.4* 0.423* 
+ ± + + + + 
5745 1.43 4.44 17.39 0.90 0.351 
40-50 145.4*' 30.7* 114.7^ 118.4* 26.7* 0.402* 
± + + + + + 
6.16 2T22 5.09 8.62 1.41 0.043 
60-70 193.1® 41.4b 151.7® 139.6* 24.6* 0.317* 
± * ± + + + 
6.04 1.48 5.77 18.29 1.30 0.Ô37 
19-25 47.8* 10.9* 36.9* 54.0* 13.1* 0.216* 
± + t + + + 
1.89 0T34 1.71 3.06 0T90 0.016 
40-50 46.6* 11.7* 34.9* 52.3* 13.1* 0.198* 
± ± ± + + + 
1.27 0.77 1.24 2.03 0.94 0.013 
60-70 46.3* 9.8* 36.5* 50.0* 13.2* 0.189* 
± ± + + + + 
2.55 0.55 2T16 2.06 0T89 0.012 
0.27* 1.38® 
a 
0.29* 0.88 
0.31* 0.89* 
0.27* 0.95* 
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Table 7. Correlation* coefficient* between *elected variable* 
Variable* 19-25 
n»10 
Age Group* (yr) 
40-50 60-70 
n»9 n»10 
All 
19-70 
n"29 
Correlation Coefficients 
Age 
Sy*tolic -0.23 -0.01 0.32 0.45* 
Dia*tolic -0.36 0.30 0.33 0.35 
Plaama Choleaterol 0.42 -0.26 -0.15 0.78** 
LOL cholesterol 0.06 0.16 -0.16 0.84** 
HWCoA reductase 0.11 -0.67 0.26 0.49** 
Chole*terol 7t%-
hydroxylaae 0.08 -0.43 0.58 0.37* 
Plasma Triglyceride 0.09 0.05 0.04 0.68** 
VLDL Triglyceride 0.27 -0.21 -0.13 0.76** 
Systolic & Diastolic 0.67* 
** 
0.81 0.56 0.64** 
Plasma Cholesterol 
Systolic 
0.23 
0.23 
0.46 
0.46 
0.02 
0.02 
** 
0.52* 
0.52 
Mononuclears (%) 
HMGCoA reductase 
0.01 
0.80** 
-0.43 
* 
0.66 
-0.49 
0.54 
-0.42* 
0.69** 
Cholesterol 70.-
hydroxylase 0.76** 0.63 0.37 0.55** 
VLDL chole*terol 0.14 0.57 0.13 0.39* 
LDL chole*terol 0.32 0.14 0.91** 0.83** 
HDL chole*terol 0.25 -0.19 -0.22 -0.08 
Plasma Triglyceride -0.16 0.36 0.79** 0.73** 
VLDL Triglyceride 0.08 0.47 0.79** 0.83** 
Systolic 
HMGCoA reducta*e 0.37 0.39 0.55 0.48** 
Chol«*t«rol 7a-
hydroxyla*e 0.42 0.64 0.65* 0.62** 
P < 0.05. 
**P < 0.01 
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Table 7, (Continued) 
Age Groups (yr) All 
Variables 19-25 40-50 60-70 19-70 
n=10 n=9 n=10 n»29 
Correlation Coefficients 
LDL cholesterol ** 
Systolic 0.33 0.48 -0.26 0.54 
** 
HMGCoA reductase 0.21 0.12 0.49 0.54 
Cholesterol TCt- ** 
hydroxylase 0.53 0.01 0.28 0.46 
Plasma triglyceride -0.19 -0.31 0.62* 0.63** 
VLDL triglyceride -0.13 -0.01 0.66* 0.77** 
Plasma triglyceride 
0.96** 0.88** 0.95** 0.95** VIDL triglyceride 
LDL triglyceride 0.59 0.41 0.69** 0.39* 
HDL triglyceride 0.68* 0.60 0.74** 0.50** 
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Table 8. Correlation coefficients between selected dietary variables, 
blood pressure, plasma leucocyte and lipoprotein llolda. 
Age Groups (yr) All 
Variable 19-25 40-50 60-70 19-70 
n«10 n=9 n=10 n"29 
Correlation Coefficient* 
Calories 
Systolic -0.37 -0.45 -0.60 -0.30 
Diastolic -0.23 -0.44 -0.35 -0.41* 
Plasma TC -0.39 -0.43 0.08 -0,27 
VLDL TC -0.79** -0.26 -0.24 -0,37* 
VLDL TG -0.61 -0.17 0.09 -0,21 
Carbohydrate 
Systolic -0.47 -0.55 -0.28 -0,35 
Diastolic -0.10 -0.68* -0.25 -0,39* 
Plasma TC -0.43 -0.43 0.06 -0.28 
Plasma TG -0.59 —0,06 -0.49 -0,41* 
VLDL TC -0.79** -0.31 -0.53 -0,46** 
VLDL TG 
fP 
-0.68 -0.04 0.43 -0,33 
LDL BA 
* 
0.66 0.25 0.39 0,47** 
Fat 
Weight 0.37 0.46 0.39 0,38* 
Leucocyte TC -0.12 -0.25 -0.55 -0,40* 
Plasma TC 0.02 -0.38 0.07 -0,24 
Plasma TG -0.53 -0.44 0.11 -0,29 
VLDL TC -0.79** 0.02 -0.01 -0,19 
VLDL TG -0.43 -0.29 0.34 -0,15 
VLDL BA 0.42 0.34 0.58 0,43* 
LDL BA 0.65* 0.31 0.07 0,36* 
HDL BA 0.44 0.29 0.53 0,46* 
*P < 0.05.. 
**P < 0.01. 
Table 8. (Continued) 
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Age Groups (yr) All 
Variable 19-25 40-50 60-70 19-70 
n=10 n=9 n=10 n«29 
Correlation Coefficients 
Protein 
Plasma TC -0,05 
Plasma TG -0.41 
Cholesterol 
Mononuclear (%) 0.62 
Plasma TC 0.004 
VL0L TC -0.17 
LDL TC 0.70* 
HDL TC -0.18 
Saturated Fat 
Mononuclear (%) 0.57 
Plasma TC 0.08 
Plasma TG -0.26 
VLDL TG -0.25 
Polyunsaturated Fat 
Mononuclear (%) 0.26 
Plasma TC 0.08 
Plasma TG -0.35 
VLDL TG -0,51 
LDL TG -0.49 
0.43 -0,32 -0.09 
0.35 -0,12 -0.12 
0,37 0.74** 0,57* 
0,21 -0.49 -0,09 
0,05 0.16 0,02 
-0,03 -0.55 -0,06 
-0,05 0.52 0,19 
** lei 
0,14 0.81 0,58 
-0.03 -0.56 -0,39* 
0,04 -0.44 -0,42* 
0,07 -0,37 -0,37* 
0,32 0,58 0,39* 
-0.07 0,002 -0,19 
0,33 -0,31 -0,35 
0,39 -0.17 -0,29 
-0,06 -0,59 -0,39* 
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DISCUSSION 
We observed a significant increase in systolic blood pressure with 
increase in age and our results are consistent with the findings of the 
HANES study [46]. The diastolic pressure also increased with age but 
not to a significant degree. As expected, analysis of our data (Table 7) 
has shown a high degree of correlation between systolic and diastolic 
pressure levels (0.64). An interdependence between serum cholesterol 
and blood pressure has often been suggested, but the relationship has 
never been clearly shown in man. Our results show significant and 
positive relationships of plasma and LDL cholesterol (free and ester) 
with systolic blood pressure and these trends are in agreement with the 
findings of Juustila [45]. Adel et al. [48] observed that ^  vivo, 
hypertensive rats synthesize cholesterol more rapidly than do normo-
tensive rats. Our results also show that the HMGCoA reductase activity 
was high in men with high systolic or diastolic pressure and this 
positive association was significant. 
No change in the total leucocyte count occurred with aging and 
this is consistent with the observations of Helman and Rubenstein [30], 
Otani [32] and Zacharski et al. [33]. We observed a decline in the 
proportion of mononuclear cells with increase in age and this trend has 
also been reported by Mackinney [34] and Reddy and Goh [35]. Friedman 
et al. [19] have reported the use of leucocyte count as a predictor of 
myocardial infarction and their data suggest that the predictive power 
of leucocyte count is quite similar to that of serum cholesterol or blood 
pressure. We did not observe any association between the total leucocyte 
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count and the plasma cholesterol or other lipids or blood pressure. 
In our study, the HMGCoA reductase activity in the mononuclear 
cells increased significantly as men aged from 19 to 50 years which was 
followed by little change in the 60-70 years. Our results do not agree 
with the observations in rats by Yamamoto and Yamamura [90j, Story and 
Kritchevsky [95j and Dupont et al. [96] who reported either a decrease 
or no change in cholesterol synthesis in liver and other extrahepatic 
tissues as the animals aged. The discrepancy may be attributed partly 
to differences in the tissue studied or in the response of humans and 
rats. The significant and positive association of both HMGK (r = 0.49) 
and COH (r = 0.37) with age also suggests a decreased function or number 
of the peripheral cell receptors which bind LDL and remove cholesterol 
from plasma. Since it is the LDL receptor binding mechanism which 
regulates cholesterol entrance and thereby synthesis within peripheral 
cells [8J any decrease in this activity will result in increased 
cholesterol synthesis and turnover by peripheral cells to meet their 
requirement of cholesterol for cell membrane synthesis. Goldstein and 
Brown [200J observed that as the rate of growth of cultured cells (human 
skin fibroblasts) declines, the number of cells receptors which bind LDL 
also decreases. Our results also suggest this trend. 
A rise in serum and LDL cholesterol with increase in age has been 
reported in many studies [52-57] and our results, too, confirm this 
trend. The increase in plasma cholesterol was almost entirely in LDL 
with insignificant increases in VLDL and Connor et al. [66] have made the 
same observation. Our results show a significant and positive association 
of plasma and LDL cholesterol levels with the HMGR and COH activity in 
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mononuclear leucocytes. This was not surprising since it has already been 
demonstrated that the leucocytes of hypercholesterolemic subjects respond 
to incubatim in a lipoprotein or lipid free medium with a greater than 
normal induction of HMGR [l3]. Under steady conditions, ^  vivo, the 
leucocytes of these subjects do not synthesize more cholesterol, 
because the higher extracellular plasma LDL cholesterol in them represses 
the HMOt. When plasma cholesterol levels increase, less efficient 
mechanisms su (A as scavenger cells or macrophages of the reticuloendo­
thelial system [zOl] become more active in degrading the increased amounts 
of LDL. These cells whoi overloaded with cholesterol esters are converted 
to foam cells, which are classic known cong)onents of atherosclerotic 
plaques. 
The proportion of free to esterified cholesterol in the plasma is 
generally considered to be relatively constmt, despite large differences 
in the amount of cholesterol present [72-74]. Our study showed the same 
trend. No studies have been noted reporting the effects of age on the 
chemical composition of different lipoproteins. Any modification in the 
chemical composition of lipoproteins can have a profound effect on 
exchangeability, accessibility end the chemical reactivity of lipid 
constituents which in turn may affect the susceptibility of peripheral 
tissues to lipid deposition [202]. Rothbalt et al. [203] have shown that 
accumulation of cholesterol esters in cell is directly related to free 
cholesterol to phospholipid ratio in HDL. Cholesterol esters accumulate 
in tissue culture cells exposed to HDL enridied in free cholesterol. 
Ahrens [lOS] and Gertler and Oppenheimer [204] suggested a relationship 
between lipid deposition in the arteries and increase in the cholesterol 
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to phospholipid ratio in plasma, and animal experiments support this 
hypothesis [205,206]. In our study, results show that as men increase 
in age, the proportion of free cholesterol to cholesterol ester in lipo­
proteins changes* the ratio in VLEfL increases whereas both LDL and HDL 
show a decrease. However, none of these changes were significant in our 
group of men. The cholesterol to phospholipid ratio increased in plasma 
and all lipoproteins even though no significant changes in their phospho­
lipid levels occurred with age. If these changes are in any way 
responsible for the increased cholesterol content of leucocytes in 60-70 
year old men studied, it is not known. 
Our results show an age related increase in plasma triglycerides, 
thus corroborating the findings of Carlson and Bottiger [106] 
and Zweers et al. [l07]. The plasma triglycerides showed a significant 
and positive correlation with all lipoprotein triglycerides, the highest 
being with VLDL triglyceride (0.95). Similar results have also been 
reported by Olsson and Carlson [67] in his study of a random sample of 40 
year old men. The significant increase in VLDL triglycerides with age 
suggests a decrease in efficiency of VLDL removal from plasma, and 
evidence for a decrease in lipoprotein lipase activity has been reported 
by Chlouverakis [207] and Boberg et al. [64], Tobey et al. [l08] also sug­
gested that the age associated increase in plasma triglycerides is due to an 
increase in VLDL triglyceride secretion and/or a relative decrease in 
VLDL triglyceride removal from plasma. 
Epidemiological evidence suggests that excessive dietary intake 
of calories or fat may be responsible for an increase in plasma cholesterol. 
The results of our study (Table 8), however, show a negative but not 
significant correlation of calorie, protein, carbohydrate, fat and chole­
sterol intake with plasma cholesterol levels. The negative correlations 
of the calorie (r = -0.37) and carbohydrate intake (r = -0.46) with VLDL 
cholesterol and of total fat intake with leucocyte cholesterol levels (r -
-0.40) were significant. We also observed a significant decrease in the 
calorie and fat intake with increase in age and similar trends have been 
observed by Munro [ll3], McGandy et al. [lié] and in the HANES study [ll4]. 
These trends suggest that the higher nutrient intake of the 19-25 year 
group of men was compensated for by their more active lifestyle^ causing a 
rapid turnover and a decrease in plasma lipids. It is also possible that 
for healthy subjects like the group we observed, the influence of dietary 
calories, fat and cholesterol on plasma cholesterol levels is overriden. 
The fat intake was related positively and significantly to all lipoprotein 
bile acids and this may be attributed to an increased turnover of bile 
acids with the increase in fat intake. 
The results of this study indicate that the diet is not responsible for 
age associated increases in plasma and leucocyte cholesterol. The increase 
may be attributed to decreased number or function of the peripheral cell 
receptors which bind and remove cholesterol from plasma. 
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GENERAL SUMMARY AND CONCLUSIONS 
The accumulation of cholesterol esters in atherosclerotic lesions 
and their lethal complications stress the importance of understanding 
cholesterol metabolism in peripheral tissues in vivo. Information on the 
control of cholesterol synthesis and utilization in peripheral tissues 
should increase our understanding of the medianisms involved in the 
formation of atherosclerotic lesions. 
This research consisted of two parts. The first part deals with the 
development of methods and a model for studying cholesterol and bile 
acid metabolism in peripheral tissues. The usefulness of leucocytes for 
studying cholesterol biosynthesis in man has already been reported. 
We demonstrated that the leucocytes can also synthesize bile acids, 
the end product of cholesterol catabolism. Evidence is presented for 
the presence of bile acids and cholesterol 7DC-hydroxylase activity 
in leucocytes and other nonhepatic tissues. The results were also 
verified by diemical ionization mass spectra. That biopsy of the 
leucocyte would allow us to study in vivo responses of peripheral tissue 
cholesterol metabolism is suggested 1) by their ability to synthesize and 
catabolize cholesterol and 2) by the fact that they are a non endocrine 
extrahepatic tissue and reflect LDL regulation of peripheral tissue 
cholesterogenesis. The second part of the study uses the leucocyte model 
for studying the effects of age and diet composition on cholesterol 
metabolism in peripheral tissues of adult men. 
After the study was approved by the Human Subjects Review Committee, 
29 healthy men from three age groups (19-25, 40-50 and 60-70 years) were 
selected. Writtoi participant coisait of the subjects and medical approval 
for participation in the study were also obtained. The 
mean body weight of the subjects in the three groups did not differ 
significantly. The subjects were instructed how to record their diet for 
three consecutive days (2 weekdays and 1 day of weekend). These records 
were analyzed for energy and nutrient content by using a computer program 
based on the food values in the Agriculture Handbook, 456. 
A 100 ml sample of fasting blood was drawn once by venipuncture. 
It was used for separation of mixed and mononuclear leucocytes and plasma 
lipoproteins. The biochemical tests performed on plasma lipoproteins and 
leucocytes included determination of cholesterol (total and free), 
phospholipids, triglycerides and bile acids. The activity of the rate 
limiting enzymes in cholesterol and bile acid synthesis hydroxymethyl 
glutaryl CoA reductase (HM(3l) and cholesterol 7X-hydroxylase (cOH) 
measured in microsomes prepared from mononuclear leucocytes. 
There were no significant differences in the number or proportion 
of different leucocytes in the three age groups studied. However, the 
mean cholesterol content of leucocytes of the oldest age group (60-70 years) 
was significantly higher than those of the two younger groups. The mean 
HMGR activity for the 40-50 year group was significantly higher than that 
for the youngest group, but similar to that of the older group. The COH 
activity for the two older age groups was higher than the mean value of 
the 19-25 year old group, but these differences were not significant. The 
plasma and LDL cholesterol values increased significantly with increase in 
age with a mean annual change of 1.57 and 1.29 mg/dl plasma respectively. 
Age had no significant affect on VLDL cholesterol. The mean HDL (Aolesterol 
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levels were similar in all three age groups. With increase in age, no 
significant Aanges were noted in the phospholipid and bile acid levels 
in plasma and lipoprotein. Plasma and VLDL triglycerides increased 
significantly with age, while LDL and HDL triglycerides were similar in 
all three age groups. 
The diet composition data show that the mean intakes of total calories, 
fat and carbohydrate of 19-25 year old men differed significantly from 
the 40-50 year old men, but not from the 60-70 year old men. The 
percentage of calories derived from protein, fat or carbohydrate was 
similar in all the three age groups. Negative and significant effects of 
dietary intake of calories and carbohydrates on VLDL cholesterol and of 
total fat intake on leucocyte cAolesterol were noted. 
Our results suggest that the age related increase in plasma and LDL 
cholesterol may reflect a decreased number or function of the peripheral 
cell receptors which bind and remove cholesterol from plasma. The results 
also indicate that the leucocytes behave as a nonendocrine, extrahepatic 
tissue with a potential usefulness as a biopsy tissue for studying 
cholesterol synthesis and degradation in peripheral tissues. A person could 
serve as his/her own control for effects of various treatments such as dif­
ferent diets or drugs. The study of leucocytes would be particularly useful 
for therapeutic regimens which decrease plasma lipids and lipoproteins but 
increase lipid deposition in peripheral tissues. 
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Statement of Information to Participants 
IOWA STATE UNIVERSITY 
FOOD AND NUTRITION DEPARTMENT 
AMES, IOWA 
TITLE OF STUDY; Effect of age and food intake on plasma lipids, lipo­
protein and cholesterol metabolism in leucocytes, 
Nina K. Dodd, Food and Nutrition Department, Ph.D. 
candidate. 
PURPOSE OF STUDY: 
Heart attack is the great plague of modern times in economically 
developed countries. Most of the time a heart attack is caused by 
atherosclerosis (hardening of the arteries) because of accumulation of 
cholesterol in the walls of arteries over a period of many years. 
He are interested in analyzing the cholesterol level in the blood 
of mean of different ages so that we may draw conclusions about how 
cholesterol changes with age and how food intake affects these changes. 
The particular part of your blood which we plan to analyze is «Aite 
blood cells because they have been shown to be a good indicator of the 
functioning of your body. 
The objectives of this research are (1) to examine the effect of 
age and food intake on cholesterol and (2) to investigate how cholesterol 
metabolism changes with age and the role this might play in atherosclerosis. 
GRADUATE STUDY COMilTTEE: 
Pilar A. Garcia, Major Professor (FN), Jacqueline Dupont (FN), 
Robert Serfass (FN), Donald Beitz (BB), and Richard Engen (VPP). 
COOPERATION! Dr. Donald Hotchkiss, statistical consultant (Statistical 
Laboratory), Dr. L. Z. Furman, medical consultant (Student 
Health Service) 
CRITERIA FOR PARTICIPATION IN THE STUDYt 
You may vAlunteer to give 100 ml of blood if 
1) You are a male and within one of these age groups: 18-25 yers., 
40-50 yra., 65-74 yrs. (10 needed for each group). 
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2) Your body weight is within the suggested desirable weight for your 
height (see table on back of this page and use range of weights 
given within parentheses). 
3) You are in apparent good health. Individuals taking drugs should 
not vèlttnteer to give blood as drugs change lipid metabolism. 
4) You are not engaged in activities such as regular jogging, swimming 
or other similar exercises. Physical activities affect the lipid 
patterns in blood. 
5) You are white (Caucasian background). Observations will be limited 
to this particular ethnic group because of the small number of 
individuals within each age group. Time and money constraints limit 
the group size that can be studied at any one time. 
6) You are willing to record your food intake for three consecutive 
days (two weekdays and one day of weekend). 
Procedure: 
Thirty men, 10 from each of the three age groups (18-25, 40-50, and 
65-74 years) will be selected. They will be taught how to record their 
food intake for three consecutive days (two weekdays and one day of the 
weekend). Their diet will then be analyzed for its nutrient content. 
Shirley Sjobakken, a registered nurse at Student Health Service (SHS) 
will record the medical history including blood pressure and ascertain 
that the subjects are in good health. Then 100 ml of fasting blbod will 
be drawn once by Linda Terry a registered medical technician at the SHS. 
Blood will be taken in the morning before breakfast. We will provide 
breakfast at the Health Service dining room. 
Risks 
Fasting blood (100 ml) will be taken from the vein by veni-puncture. 
Minimal risks, like the possible formation of a bruise like area (hematoma) 
and infection are involved. All blood will be drawn by a registered 
medical technologist at the Student Health Service under stringent aspectic 
conditions to minimize the risks. Some minimal pain is involved in 
drawing blood but this should be no greater than the discomfort experienced 
irtien blood tests are made during medical examination. 
FOR YOUR PARTICIPATION, you will receive: 
1) Ten dollars to cover time spent going to health service. 
2) A copy of your diet analysis. 
3) Results obtained from this study upon request. 
4) Transportation to and from the health service if needed. 
Ill 
Fasting Blood Samples 
TIME: Before breakfast between 7:00 and 8:00 A.M. 
at University Student Health Service 
By: Registered Medical Technician 
The night before a fasting blood sample is taken: 
DO NOT EAT OR DRINK ANYTHING AFTER 10:00 P.M. 
The following morning a saiqple is taken: 
DO NOT EAT OR DRINK ANYTHING. 
We will provide breakfast at the Health Service dining room 
Dates when seunples will be taken; 
February 21, 1981. Friday 
February 25, 1981. Wednesday 
March 2, 1981. Monday 
BE AT HEALTH SERVICE BY 7:00 A.M. 
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Food and Nutrition Department 
Iowa State University 
Ames, Iowa 50011 
Participant Informed Consent 
I, , have been informed verbally and in writing of the 
purpose, benefits, and potential hazards of the study entitled "Effect of 
age and food intake on plasma lipids, lipoproteins and cholesterol 
metabolism in leucocytes in men" by Nina Dodd. 
I volunteer of my own free will to participate fully in this study. I 
understand that I will be given further explanation of the study and of 
specific procedures, if I so desire. I also understand that I may withdraw 
from the study at any time and that I am not waiving my legal rights. I 
understand that my records will be handled in a confidential manner as 
medical records, and that I will be given access to my records during and 
at the end of the study, if I so desire. 
I understand that emergency treatment of any injuries that may occur as a 
direct result of participation in this research will be treated at the Iowa 
State University Student Health Services, Student Services Building, and/or 
referred to Mary Greeley Hospital or another physician. Compensation for 
treatment of any injuries that may occur as a direct result of participa­
tion in this research may or may not be paid by Iowa State University 
depending on the Iowa Tort Claims Act. Claims for compensation will be 
handled ty the Iowa State University Vice President for Business and 
Finance. 
Signature 
Witness 
Date 
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Medical Clearance Statement 
TOI Personal Physician of 
Name of volunteer 
From; Nina Dodd, Ph.D. Candidate and Dr. P. A. Garcia, Professor 
Food and Nutrition Department 
33A MacKay Hall 
Iowa State University 
Ames, Iowa 50011 
Date* February 6, 1981 
We are studying the effects of age and food intake on plasma lipids, 
lipoproteins and cholesterol metabolism in leucocytes in men. The purpose 
and procedure to be used are described in the statement of information to 
participants and a copy is attached together with the Pairticipants 
Informed Consent. 
To participate in our program, the individual must meet the following 
criteria: (a) male, (b) be in one of the age groups of 18-25 years, 
40-50 years, and 65-74 years, (c) body weight is within the suggested 
desirable wei^t for his height, (d) not taking drugs, (e) not doing 
regular jogging or swimming or any similar exercises, (f) is in apparent 
good health. 
Your patient has volunteered to 
Name 
participate in our program and we would appreciate your medical recommenda­
tion concerning his/her decision. Please complete the form below and 
return to me. 
Please check* 
I have no reservation regarding this patient's participation in 
your study. 
_______ I have reservations regarding this patient's participation in your 
study. My reservations are as follows* 
a. 
b. 
c. 
Signature of Physician Date 
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Directions for Food Intake Records 
1. PLEASE EAT AS YOU DO ORDINARILY so that your intake will reflect your typical 
pattern of eating. 
2. Write down everything you eat or drink for three (3) consecutive days 12 week 
days and 1 day of the weekend) on the Food Record form. 
3. Write down your name, date of record and information about yourself on each 
sheet. 
4. Use the attached SAMPLE FOOD RECORD as your guide. 
5. Describe foods eaten as accurately as you can. Exaiqples are: 
Meats: Ground beef patty, pan-bxoiled; Breaded pork chop; Fried chicken breast 
Fruits: Small, medium or large 
Fresh Canned Fruits : Water pack, juice pack, light syrup, heavy syrup 
Breads: White enriched; White unenriched; 100% Whole Sheat; I^e; 
Special Brands, thin or thick sliced 
Cereals: Oatmeal; Wheaties; with whole milk; with cream; with sugar, etc. 
Condensed Soups: prepared with milk or water 
Salads: Tomato-Lettuce; Apple, celery, nuts with mayonnaise; with French dressing 
Milk: Whole; 2%; skim; buttermilk 
Casseroles and Mixed Dishes: List and estimate ingredients used 
Vegetables: Raw, cooked, canned - vacuum or liquid pack 
6. Estimate amounts eaten as carefully as you can and record amounts in household 
measures, ounces or untis as suggested below: 
Bread Slice 
Meats; Cheese Ounces (oz.) See other side 
Beverages: Cereals; Canned 
Fruits; Cooked Vegetables Cups (c.) 
Fresh fruits Small, medium, large. Measure on berries. 
Butter; Margarine; gravy; 
Salad Dressings; Toppings teaspoon (tsp.); Tablespoon Clbsp.) 
Sugar; Jellies; Jam; Sugar Syrups teaspoon (tsp.); Tablespoon (Tbsp.) 
Cake, Cookies Measure in inches 
Carbonated Beaverages, 
Alcoholic Beverages Ounces (oz.) 
7. Indicate time of day fbod is eaten as morning meal, noon meal, evening meal 
or in-between meals (snacks). 
8. If you are taking any vitamin or mineral pills, write down the kind and how often 
you take them. This will not be coded, but the information can be added individually. 
THE MORE ACCURATE THE RECORD, THE MORE ACCURATE THE ANALYSIS 
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APPENDIX Bi METHODOLOGY 
Selection of Subjects 
Thirty men, 10 from each of three age groups (18-25, 40-50 and 65-74 
yrs) were selected. None of the subjects was engaged in activities such 
as regular jogging, swimming or other training exercises. Their body 
weights were in the desirable weight range for their height. Medical 
approval of the subjects was obtained to ascertain that they were in good 
health. Because of the small number of individuals within each age group, 
all subjects were white (Caucasian background). 
Blood Collection 
A 100 ml sample of fasting blood was drawn from the vein by veni­
puncture by a registered medical technician at the Student Health Service, 
under aseptic conditions to minimize the risks. The blood 
sanqiles were processed as follows: 40 ml of blood was used for counting 
the number and proportion of leucocytes and for plasma and lipoprotein 
separation, 30 ml was used for separation of mononuclear cells and 30 ml 
for separation of mixed leucocytes. 
Counting the Total Number of Leucocytes 
Forty p,l of blood was diluted with 20 ml of i so ton to give It 501 blood 
dilution. To this 6 drops of zap isoton was added to destroy red 
cells and the solution was mixed well. The aperture of the tube of a 
Coulter counter was immersed into the diluted blood and the total number of 
leucocytes recorded. Three determinations were made for each sample and 
the average used as the total number of leucocytes. 
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Differential Count of Leucocytes 
Ehumeration of the proportion of different kinds of leucocytes was 
done by examining a blood smear stained with Wright's stain under a micro­
scope [196]. A freshly made blood smear was air dried, covered completely 
with Wright stain for 3-4 minutes and then washed with water until a 
yellowish or pink film was left. This was allowed to dry and then examined 
under the microscope. 
Isolation of Mixed Leucocytes 
Mixed leucocytes were isolated by following the Young and Rodwell 
method [ll]. Ten ml of blood drawn in the presence of Na^EDTA was placed 
in a 50 ml polycarbonate centrifuge tube containing 10 ml of 3% Dextran TSOO 
in 0.9% NaCl. The erythrocytes were allowed to clump and settle for 45 
minutes at room temperature and were then further sedimented by centri-
fugation (25 g, 10 min.). The supernatant liquid was removed and centri-
fuged at 300 g for 30 minutes to sediment the leucocytes. The leucocyte 
pellet was resuspended in Buffer I which contains 250 mM NaCl, SmM 
5 mM dithiothreitol and 50 mM K^HFO^ at pH 7.5. The suspenslcm was stored 
in liquid Ng. 
Isolation of Mononuclear Leucocytes 
Mononuclear cells were isolated by layering over Ficoll-Paque, 
according to the method described in the Manual of Clinical Immunology 
[159], Blood drawn in the presence of heparin was diluted with an equal 
volume of balanced salt solution and layered over 5 ml of Ficoll-Paque 
a 50 ml glass tube. Blood was added in such a way that the Ficoll-Paque 
layer was not disturbed. This was centrifuged at 1450 for 40 minutes. 
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The top layer on Ficoll-Paque, which consists of romonuclear cells was 
removed. Monocytes were separated from lymphocytes by adherence to culture 
flasks. 
Isolation of Granulocytes 
The lower Ficoll-Paque band contains granulocytes. This layer was 
removed and granulocytes were isolated. Any red cells contaminating were 
removed by washing with cold 0.85% NH^Cl. 
Isolation of Leucocyte Microsomes 
The frozen leucocyte pellet was incubated at 37°C until just thawed. 
The suspension was homogenized for 15 sec. in a Potter-Elvehjem tissue 
grinder and the homogenate was centrifuged at 8000 g for 10 min. The 
supernatant was removed by a Pasteur Pipette to an ultracoitrifuge tube 
which also filled with Buffer I. This was centrifuged at 113,000 g for 
2 hours. The microsomal pellet was suspended in Buffer I by homogenization. 
Separation of Plasma and Lipoproteins 
Blood was centrifuged at 1000 g for 10 minutes at 4^C for separation 
of plasma. Plasma lipoproteins were separated by ultracentrifugation [195] 
into 3 major fractions - very low density lipoprotein (VLDL), low density 
lipoprotein (LDL 1.006-1.063) and high density lipoprotein (HDL 1.063-1.21). 
Ultracentrifugation of plasma for 18 hours at 20,000 g allowed the VLDL 
fraction to be collected at the top of the tube, from where it was removed 
salt (KBr) was added to the remaining (LDL + HDL) fraction to raise its 
density to 1.063 for isolation of LDL, after VLDL was removed. This was 
recentrifuged at 120,000 g for 24 hours and LDL removed from the top of the 
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tube. HDL + HDL bottom was centrifuged at 120,000 g for 48 hours to isolate 
HDL, after the density of the solution was increased from 1.063 to 1.21 by 
addition of KBr solution. 
Chemical Analyses 
All determinations were done in duplicate and averaged. 
Cholesterol Analyses 
Total and free diolesterol (TC & FC) concentrations were determined 
by the method of Allain et al. [l79]. Esterified cholesterol (CE) is 
calculated by the difference between TC and FC. A 10 ^ 1 sample of plasma 
and lipoprotein was used for total cholesterol and a 30 p,! saiqple for 
free cholesterol. To this was added 0.5 ml of oofactor solution made in 
sodium phosphate buffer (pH 7) containing 612.9 p.g of sodium cholate, 
81.3 pg of 4 aminoantipyrine, 658 pig of crystalline phenol, 510 ^ g of 6000 
carbowax, 0.06 unit of cholesterol oxidase, 0.01 unit of cholesterol ester 
hydrolase and 33.8 units of horseradish peroxidase. The mixture was 
incubated at 37°C for 10 minutes, cooled and read at 500 nH in a spectro­
photometer. The mixture for free cholesterol does not contain any 
cholesterol ester hydrolase. Concentrations of unknown samples were 
determined from a standard curve constructed by using diolesterol standards 
in isopropanol. Free and total cholesterol concentration of a sample were 
assayed on the same day. 
Phospholipid Analyses 
Phospholipid (PL) was assayed using a modification of the method of 
Sandhu [l97]. 100 |il sample of plasma or lipoprotein was extracted with 
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1.5 ml of isopropanol. Standards were prepared from a solution of lecithin 
in hexane (2 mg/ml). Sanqile, standard and aliquot of isopropanal as blank 
were evaporated to dryness in a block heater at 100°C. To the residue, 
0.4 ml of chloroform and 0.1 ml of chromogenic solution (ammonium moly-
bda te IH gSO^ * me thanolichloroform* wa ter) were added and contents were 
mixed for S s heated at lOO^C for 1 min. After cooling, contents were mixed 
for 5 s and after S minutes 2 ml of nonane was added. The mixture was 
centrifuged at 2400 rpm for 3 minutes and absorbance of supernatant was 
recorded at 710 nM in a spectrophotometer. Phospholipid concentrations 
were calculated from the lecithin standard curve. 
Triglyceride Analyses 
Triglyceride in plasma and lipoproteins were estimated by the method 
of Fletcher [198] with slight modification. A 0.2 ml sample or standard 
(300 mg triolein/100 ml isopropanol) was extracted with 4.8 ml of 
isopropanol by centrifugation at 800 g for 5 minutes. To 2 ml of clear 
supernatant was added 0.5 ml of 1 N potassium hydroxide and the mixture 
was Incubated at 60°C for 5 minutes. Then 0.5 ml of sodium periodate 
solution (.025 M in 1.0 N acetic acid) and after 10 minutes color reagent 
(20 ml of 2 M ammonium acetate, 40 ml of isopropanol and 0.15 ml of 
acetylacetone) were added. The mixture was mixed well, incubated at 
60°C for 30 minutes, cooled and read at 415 nM. Triglyceride concentrai 
tions in saiq>les is calculated from the standard curve. 
Total Bile Acid Analyses 
A modification of the method of Turnberg et al. [18l] was used for 
assaying total bile acid concentration in plasma and lipoprotein samples. 
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To 0.1 ml of sanqple or standard was added 0.5 ml of 0.005 M $ NAD and 
0.6 ml of 0.1 H sodium pyrophosphate buffer. This was allowed to 
equilibrate at 25°C for IS minutes and absorbanee of the mixture was 
recorded at 340 nm. Then 0.1 ml of 3a hydroxysteroid dehydrogenase was 
added and change in absorbance was read at 340 nm after letting it sit 
for 40 minutes. Total bile acid concentration of unknown saiqples is 
read from the plot of change in absorbance vs. concentration. 
Hydroxymethylglutaryl Coenzyme A Reductase 
(HMGCqA Reductase) Assay 
HMGCqA reductase activity was measured in leucocyte microsomes by 
a slight modification of the Young and Rodwell method [ll]. A 100 ^ 1 
sample of microsomal suspension containing 0.75 mg of protein was added 
to 50 ^1 of substrate-cofactor solution to give final concentrations 
as follows* 20 nM[3-^^c] HMG-CoA sp act 58.6 mci/mnol (.07 ^  ci per assay), 
3 nM NADP, 30 IM glucose 6 phosphate and 0.3 units of glucose-6 phosphate 
dehydrogenase. The mixture was incubated at 37°C for 60 min. The 
reaction was stopped by adding 100 ^ 1 (40,000 dpm) of [5-^8] mevalanol-
actone as an internal standard. This was incubated for 15 minutes at 37°C 
to lactonize the mevalonate formed and then centrifuged (10,000 g) for 
2 minutes to sediment protein. About 0.5 g of sodium sulfite was added 
to each tube (pH ~ 6.5) and mixture was extracted thrice with 5 ml of 
benzene. The benzene extract was dried and counted with 10 ml of Bray's 
solution in liquid scintillation counter using external standard channel 
ratio. The calculations were done as follows: 
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« c£ u 
added 
Cholesterol 7a-Hydroxylase Assay 
Cholesterol 7a-hydroxylase assay in leucocyte and tissue microsomes 
was done using Carlson et al. method [163] with following modifications. 
The [4-^*c] cholesterol (54 ci/mol) was purified by TLC using 
benzene/ethyl acetate (2t3 v/v) with a standard in an adjacent channel. 
The plate was broken in half and standard was sprayed with 50% HgSO^ and 
heated in an oven for 1-2 min. A comparable band on the section of plate 
14 
containing 4- C cholesterol was scraped and extracted with acetone. This 
was evaporated under Ng to reduce volume to give approximately 2 x lO^cpm 
per 150 |il. The cholesterol suspension was prepared by adding Tween 80 
(0.36 mg per assay) to cholesterol in acetone, evaporating to dryness 
under nitrogen and resuspending residue to appropriate volume with 
deionized water. 
Microsomal suspension (0.3 ml) in homogenizing buffer was incubated 
at O^C for 10 minutes with 0.3 ml of potassium phosphate buffer (pH 7.4) 
containing 35 mH 3 mercaptoethanol, 0.15 ml of 4.5 mM MgCl2 #nd 0.15 ml 
of cholesterol suspension. This is to allow equilibration of exogenous 
and microsomal cholesterol. Substrate cofactor solution (0.15 ml) 
containing 0.75 mM NADP* 3 mM glucose 6 jAiosphate and 0.15 units of glucose 
6 phosphate dehydrogenase are then added. The mixture is incubated at 
37°C for 40 minutes with shaking. Blanks containing boiled microsomal 
suspension were also treated in the same manner. The reaction was stopped 
with 2 ml of ethanol and extracted with petroleum ether, after vortexing. 
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The extract Mas dried under nitrogen» dissolved in 0.125 ml of benzene/ 
methanol (4*1, v/v) and applied to TLC plate under nitrogen, with 
cholesterol and 7a-hydraxycholesterol as a standard. The plates were 
developed with benzene/ethyl acetate (2*3) for 40-45 minutes. Cholesterol 
and 7a-hydroxycholesterol were identified by spraying with 50% H^iSO^ and 
these bands were removed and assayed for radioactivity with scintisol 
using liquid scintillation spectrometry. The calculations were done as 
follows* 
^conversion of [4-^*C]-cholesterol to [4-^^C]-7a-hydroxychole8terol 
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APPENDIX Ct INDIVIDUAL DATA OF EACH SUBJECT 
Table C-1. Age, weight, blood pressure and leucocyte count in men of 3 age groups 
Age Subject Age Height Systolic Diastolic Leucocyte Mononuclear 
Group Number (yrs) (lbs) (mm H») (mm Ho) Count Leucocytes 
(yrs) (%) 
1 22 175 118 74 10897 35 
2 24 186 118 76 7130 43 
3 24 189 —— 6300 35 
4 20 176 124 70 5955 48 
5 25 194 94 56 6522 50 
6 22 143 100 68 7153 48 
7 23 199 152 84 7794 63 
8 19 156 120 80 5960 43 
9 22 164 122 58 6153 41 
10 23 176 118 66 8079 35 
Mean 22 176 118 70 7194 44 
(%) 
35 
55 
46 
40 
24 
40 
29 
39 
54 
40 
(Continued) 
Subject Age Weight Systolic Diastolic Leucocyte 
Number (yrs) (lbs) (mm Hg) (mm Hg) Count 
1 44 172 88 64 7986 
2 46 179 106 74 5357 
3 50 155 116 86 4337 
4 47 172 140 98 6282 
5 41 136 124 80 7083 
6 40 207 130 84 6729 
7 42 110 72 7998 
8 40 162 112 70 7220 
9 45 208 114 62 5451 
44 174 116 77 6494 
Table C-1. (Continued) 
Age 
Group 
(yrs) 
Subject 
Number 
Age 
(yrs) 
Weight 
(lbs) 
Systolic 
(mm Hg) 
Diastolic 
(ran Hg) 
Leucocyte 
Count 
Mononuclear 
Leucocytes 
(%) 
1 67 165 136 78 6072 40 
2 68 178 128 86 7956 29 
3 67 167 156 96 7532 31 
4 62 165 134 84 6961 36 
60-70 5 63 127 138 68 6350 61 
6 65 169 152 74 8115 40 
7 62 183 134 78 7400 39 
8 61 191 120 76 7240 28 
9 62 195 148 90 13783 36 
10 63 186 120 58 6754 29 
Mean 64 173 137 79 7816 38 
Table C-2. Diet conyosition of each subject (mean of 3 days) 
Age 
Group 
(yrs) 
Kcals Protein 
(g) 
Carbohydrate 
(g) 
Fat 
(g) 
Saturated 
Fat(g) 
(Total) 
Oleic 
(g) 
Linoleic 
(g) 
P/S Cholesterol 
(mg) 
2981 125 312 143 39.2 40.7 8.90 0.227 393.1 
2539 81 339 99 44.1 33.8 10.30 0.233 276 .5 
2066 77 219 101 31.6 33.9 13.20 0.418 266.2 
19-25 3135 100 368 147 44.9 44.8 16.30 0.363 762.2 
2998 97 304 159 50.6 63.7 24.80 0.490 420.0 
3772 143 489 124 51.2 49.4 29.70 0.580 409.2 
2811 132 266 136 64.2 49.9 21.10 0.329 712.9 
2136 93 252 88 76.2 60.1 50.40 0.661 646.4 
2432 66 244 80 34.5 32.7 10.90 0.316 215.4 
Mean 2763 102 310 120 48.5 45.4 20.6 0.402 455.7 
Table C-2. (Continued) 
Age 
Group 
(yrs) 
Kcals Protein 
(g) 
Carbohydrate 
(g) 
Fat 
(6) 
Saturated 
Fat(g) 
(Total) 
Oleic 
(g) 
Linoleic 
(g) 
P/S Cholesterol 
(mg) 
2129 95 212 99 42.1 30.4 10.10 0.239 291.3 
1481 60 184 58 32.4 40.8 14.40 0.444 667.2 
2899 106 278 108 21.1 22.5 8.50 0.403 170.4 
751 26 72 41 43.8 33.4 13.90 0.317 474.6 
40-50 
1134 42 145 42 32.4 53.4 13.90 0.429 467.5 
2160 86 179 119 14.8 14.2 6.30 0.426 160.9 
2239 107 239 98 13.4 15.2 9.50 0.708 119.4 
2213 79 266 90 32.8 33.6 17.90 0.545 253.2 
2333 95 296 90 34.9 26.5 19.10 0.547 413.0 
Mean 1927 77 208 83 29.7 30.0 13.6 0.451 335.3 
Table C-2. (Continued) 
Age 
Group 
(yrs) 
Kcals Protein 
(g) 
Carbohydrate 
(g) 
Fat 
(g) 
Saturated 
Fat(g) 
(Total) 
Oleic 
(g ) 
Linoleic 
(g) 
P/S Cholesterol 
(mg) 
2127 64 263 68 26.5 24.1 10.90 0.411 256.6 
2291 78 323 67 18.3 15.7 4.20 0.229 177.1 
2225 235 196 116 38.2 38.7 9.90 0.259 369.9 
1903 75 164 89 29.5 26.5 9.90 0.335 601.6 
60-70 1991 94 237 73 75.1 72.2 22.20 0.295 837.7 
1363 65 172 48 31.9 32.3 12.10 0.379 263.4 
2193 77 357 61 29.5 30.7 25.20 0.854 556.3 
2779 119 335 103 20.3 26.7 14.50 0.714 340.0 
2650 92 246 126 47.9 53.8 23.60 0.492 548.7 
3701 156 283 192 19.3 22.3 8.96 0.464 199.6 
Mean 2322 106 258 94 33.6 34.3 14.1 0.443 415.1 
Table C-3. HMGCoA reductase (HMG) and cholesterol 7a-hydroxylase (COH) activity 
in mononulcear leucocyte 
Age HMG COH HMG COH HMG COH 
Group (per mg microsomal (per ml blood) (per 10' mononuclear 
(yrs) protein) leucocytes) 
9.3 0.095 9.8 0.100 25.7 0.262 
9.9 0.101 7.6 0.077 24.7 0.251 
13.8 0.128 12.4 0.115 56.2 0.521 
11.1 0.113 9.2 0.093 32.2 0.326 
19-25 9.5 0.098 8.2 0.085 25.1 0.260 
11.4 0.104 8.1 0.073 23.6 0.214 
12.4 0.132 10.5 0.112 21.4 0.227 
10.3 0.108 9.8 0.102 38.2 0.397 
7.7 0.065 7.2 0.061 28.5 0.242 
10.2 0.116 8.2 0.093 28.9 0.331 
Mean 10.5 0.106 9.1 0,091 30.4 0.303 
Table C-3. (Continued) 
Age HMG COH HMG COH HMG COH 
Group (per mg microsomal (per ml blood) (per 10^ mononuclear 
(yrs) protein) leucocytes) 
11.4 0.079 9.9 0.069 35.4 0.234 
11.5 0.096 10.6 0.089 39.9 0.447 
8.7 0.092 12.4 0.131 62.1 0.522 
13.4 0.114 11.9 0.101 47.3 0.404 
40-50 
16.9 0.131 16.5 0.128 97.1 0.753 
14.3 0.108 9.0 0.068 33.4 0.253 
12.7 0.116 13.4 0.122 57.8 0.525 
13.9 0.109 12.2 0.096 43.3 0.340 
15.4 0.116 13.6 0.087 46.2 0.296 
Mean 13.1 0.107 12.2 0.099 51.4 0.419 
Table C-3, (Continued) 
Age HMG COH HMG COH HMG COH 
Group (per mg microsomal (per ml blood) (per 10 mononuclear 
(yrs) protein) leucocytes) 
11.9 0.151 8.7 0.110 35.8 0.453 
17.3 0.156 14.0 0.126 60.7 0.547 
15.6 0.148 13.7 0.130 58.7 0.557 
12.1 0.112 12.6 0.116 50.3 0.464 
60-70 9.6 0.091 10.3 0.097 26.6 0.252 
18.8 0.159 14.3 0.120 44.1 0.372 
13.9 0.142 11.9 0.121 41.2 0.419 
9.7 0.058 9.9 0.059 35.9 0.216 
21.4 0.165 16.9 0.130 34.1 0.262 
13.6 0.098 12.8 0.092 65.3 0.472 
Mean 14.4 0.128 12.5 0.110 45.2 0.401 
Table C-4. Total cholesterol (TC) and free cholesterol (FC) levels in plasma, 
lipoproteins and leucocytes 
Age Plasma Plasma VLDL VLDL LDL LDL HDL HDL Leucocyte Leucocyte 
Group TC FC TC FC TC FC TC FC TC FC 
(jrrs) mg/dl plasma 8 lie oer 10 cells 
190 47.4 19 4.9 120 33.6 47 10.8 139 112 
193 45.4 19 4.2 112 24.5 52 11.6 142 110 
241 62.7 24 5.7 118 26.4 49 10.6 44 34 
191 49.7 20 5.1 121 31.9 46 11.8 121 106 
19-25 208 55.2 16 3.7 125 25.4 61 12.5 98 82 
195 50.3 17 3.9 123 29.8 47 9.5 45 34 
216 60.5 19 3.9 149 32.1 49 11.3 65 38 
202 56.6 24 5.8 127 32.3 39 9.3 111 82 
182 . 50.9 25 5.2 111 28.6 42 9.9 139 112 
209 54.2 21 4.9 166 39.7 44 11.7 102 72 
Mean 204 53 25 4.7 127 30.4 48 10.9 101 78 
Table C-4. (Continued) 
Age Plasma Plasma VLDL VLDL LDL LDL HDL HDL Leucocyte Leucocyte 
Group TC FC TC FC TC FC TC FC TC FC 
mg/dl plasma u.g per lO^cells 
215 53.7 2 5 5,5 138 32.8 4 7 13.9 162 1 24 
213 55.1 21 4.3 141 23.9 48 12.6 172 128 
218 61.1 11 3.2 149 22.6 51 11.9 55 41 
40-50 232 64.8 22 4.6 160 31.4 40 10.3 78 64 
308 89.3 27 5.7 130 35.2 45 12.3 137 101 
254 71.2 34 8.4 1 79 38.8 4 4 9.2 117 83 
216 58.3 24 4.1 129 22.8 46 14.6 88 70 
194 46.3 14 3.3 132 29.2 46 7.4 69 48 
239 56.4 28 8.7 171 40.2 53 12.8 73 52 
Mean 232 62 21 5.3 145 30.7 47 11.7 106 79 
Table C-4. (Continued) 
Age Plasma Plasma VLDL VLDL LDL LDL HDL HDL Leucocyte Leucocyte 
Group TC FC TC FC TC FC TC FC TC FC 
(yrs) 
mg/dl plasma 
g |ie per 10 cells 
291 84.4 24 6.3 204 46.8 49 12.8 114 90 
272 73.4 13 3.9 208 42.7 44 9.5 143 93 
257 66.8 21 4.5 178 40.2 49 10.4 66 52 
279 72.7 22 5.2 199 34.1 40 8.2 128 107 
60-70 226 65.5 31 10.1 157 33.2 55 12.9 71 55 
317 85.6 37 6.4 209 39.6 43 8.9 193 141 
295 75.4 20 6.4 211 41.3 64 12.3 360 249 
286 69.1 21 6.7 208 41.1 38 8.7 114 83 
309 71.1 23 7.7 221 46.8 49 8.9 113 88 
294 72.7 28 8.2 213 45.2 39 7.7 53 42 
Mean 283 74 25 6.5 193 41.4 46 9.8 135 100 
Table C-5, Phospholipid (PL) and triglyceride (TG) and bile acid levels in plasma and lipoproteins 
Age Plasma HDL LDL VLDL Plasma VLDL LDL HDL Plasma HDL LDL VLDL 
Group PL PL PL PL _TG TG TG TG BA BA BA BA 
mg/dl plasma p. Moles/dl plasma 
266 63 161 40 98 56 29 10 0.895 0.294 0.42 0.161 
134 51 56 26 102 61 26 15 0.680 0.210 0.30 0.114 
276 64 164 43 94 58 22 11 0.340 0.105 0.15 0.084 
183 47 107 28 84 48 23 12 1.150 0.243 0.69 0.119 
139 49 64 25 82 49 26 11 0.910 0.206 0.59 0.098 
277 62 170 43 79 43 22 13 0.920 0.221 0.59 0.094 
289 65 184 37 104 63 23 17 0.770 0.263 0.39 0.103 
160 38 73 29 90 51 23 14 0.410 0.210 0.30 0.098 
139 43 59 29 114 64 30 18 0.760 0.221 0.43 0.094 
234 58 181 32 88 51 24 10 0.660 0.185 0.37 0.087 
Mean 210 54 122 33 93 54 24 13 0.749 0.216 0.423 0.105 
Table C-5, (Continued) 
Age Plasma HDL LDL VLDL Plasma VLDL LDL HDL Plasma HDL LDL VLDL 
Group PL PL PL PL TG TG TG TG BA BA BA BA 
mg/dl plasma p, Moles/dl pla'na 
216 52 135 28 89 52 27 9 0.820 0.178 0.51 0.108 
179 54 96 28 96 51 30 12 0.760 0.168 0.48 0.099 
234 63 135 34 118 67 31 18 0.920 0.206 0.59 0.107 
220 45 141 32 114 69 28 12 0.440 0.146 0.21 0.066 
257 54 162 34 127 78 31 14 1.410 0.252 0.36 0.123 
197 58 102 35 94 62 19 11 0.720 0.244 0.35 0.107 
183 43 104 28 106 59 29 17 0.740 0.238 0.34 0.138 
154 50 82 21 117 74 24 13 0.560 0.174 0.25 0.096 
231 52 109 29 106 68 22 12 0.540 0.182 0.26 0.092 
Mean 208 52 118 30 107 64 27 13 0.767 0.198 0.402 0.104 
Table C-5, (Continued) 
Age Plasma HDL LDL VLDL Plasma VLDL LDL HDL Plasma HDL LDL VLDL 
Group PL PL PL PL TG TG TG TG BA BA BA BA 
Cyrs) mg/dl plasma p, Moles/dl plasma 
187 52 101 31 131 86 29 12 0.720 0.238 0.34 0.117 
130 44 66 21 112 72 25 14 0.96 0.210 0.61 0.102 
313 59 221 28 121 82 27 11 0.62 0.210 0.30 0.096 
200 39 130 27 138 95 24 17 0.35 0.161 0.23 0.094 
60-70 224 54 147 23 88 58 17 10 0.53 0.147 0.26 0.092 
299 52 208 39 148 97 31 19 0.49 0.161 0.23 0.088 
176 54 94 26 109 75 21 12 0.41 0.133 0.19 0.069 
104 41 68 26 118 79 27 11 0.64 0.182 0.36 0.096 
254 55 156 40 137 101 22 13 0.64 0.224 0.31 0.096 
261 50 205 42 126 92 23 13 0.73 0.226 0.34 0.124 
Mean 215 50 140 30 122 84 25 13 0.609 0.189 0.317 0.097 
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